Table of Contents

 

As filed with the Securities and Exchange Commission on February 2, 2010August 22, 2014

Registration Statement No. 333-164241333-          

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

PRE-EFFECTIVE AMENDMENT NO. 1

TOFORM S-3

 

FORM S-3

REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

 


 

SUMMER INFANT, INC.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of
incorporation or organization)

 

20-1994619

(State or other jurisdiction of

incorporation or organization)


(I.R.S. Employer


Identification No.)

 

1275 Park East Drive

Woonsocket, Rhode Island 02895

(401) 671-6550

(Address, including zip code, and telephone number, including

area code, of registrant’s principal executive offices)

 


 

Joseph DriscollPaul Francese

Chief Financial Officer

Summer Infant, Inc.

1275 Park East Drive

Woonsocket, Rhode Island 02895

(401) 671-6550

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 


 

Copies to:

 

John M. Bello,Elizabeth W. Fraser, Esq.

Greenberg Traurig, LLP

One International Place

Boston, Massachusetts 02110

Telephone: (617) 310-6000310-6237

Telecopy:Facsimile: (617) 310-6001279-8427

 

Approximate date of commencement of proposed sale to public:From time to time after the effective date of this Registration Statement becomes effective.Statement.

 

If the only securities being registered on this Formform are being offered pursuant to dividend or interest reinvestment plans, please check the following box.  o

 

If any of the securities being registered on this Formform are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.  x

 

If this Formform is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

If this Formform is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

If this Formform is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.  o

 

If this Formform is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o

 

Accelerated filer o

Non-accelerated filer o (Do
(Do not check if a smaller reporting company)

 

Smaller reporting company x

 


 

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

 

 

 

 

Title of Each Class of Securities to be Registered

 

Amount
to be
Registered (1)

 

Proposed
Maximum

Offering Price
Per Unit

 

Proposed
Maximum
Aggregate
Offering Price

 

Amount of
Registration
Fee (3)

 

Common Stock, $.0001 par value per share

 

 

 

 

(2)

 

(2)

 

 

Preferred Stock, $.0001 par value per share

 

 

 

 

(2)

 

(2)

 

 

Warrants

 

 

 

 

(2)

 

(2)

 

 

Purchase Contracts

 

 

 

 

(2)

 

(2)

 

 

Depositary Shares (4)

 

 

 

 

(2)

 

(2)

 

 

Rights

 

 

 

 

 

 

 

 

 

Units (5)

 

 

 

 

(2)

 

(2)

 

 

Total

 

$

100,000,000

 

 

 

$

100,000,000

 

$

5,580.00

 

Title of each class of securities to be registered

 

Amount
to be
registered (1), (2), (3)

 

Proposed
maximum

offering price
per unit (3)

 

Proposed
maximum aggregate
offering price
(3), (4), (5)

 

Amount of
registration
fee (3)

 

 

 

 

 

 

 

 

 

 

 

Common Stock, $0.0001 par value per share

 

 

 

 

 

 

 

 

 

Preferred Stock, $0.0001 par value per share

 

 

 

 

 

 

 

 

 

Warrants

 

 

 

 

 

 

 

 

 

Debt Securities

 

 

 

 

 

 

 

 

 

Subscription Rights

 

 

 

 

 

 

 

 

 

Units (6)

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

$

30,000,000

 

$

3,864.00

 

(1)                       There are being registered under thisThis registration statement also covers common stock or preferred stock that may be issued by the registrant upon exercise, conversion or exchange of any securities registered hereunder that provide for such issuance.  An indeterminate number of shares of common stock and preferred stock; such indeterminate number of depositary shares; such indeterminate number of warrants to purchase common stock, preferred stock, depositary shares and/or units; such indeterminate number of purchase contracts to purchase common stock, preferred stock, depositary shares or warrants; such indeterminate number of rights to purchase common stock, preferred stock, depositary shares or warrants; and such indeterminate number of unitsthe securities is being registered as may at various times be sold by the registrant from time to time, which together shall haveissued at indeterminate prices, with an aggregate initial offering price not to exceed $100,000,000. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. The securities registered hereunder also include such indeterminate number of shares of common stock and preferred stock, depositary shares, and warrants as may be issued upon conversion of or exchange for preferred stock or depositary shares that provide for conversion or exchange; upon exercise of warrants, purchase contracts or rights; or pursuant to the anti-dilution provisions of any such securities. In addition, pursuant$30,000,000.

(2)Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock asthis registration statement also covers any additional securities that may be issuableoffered or issued in connection with respect to the shares being registered hereunder as a result ofany stock splits,split, stock dividends,dividend or similar transactions.transaction.

 

(2)(3)                       Not requiredPursuant to be included in accordance with General Instruction II.D. of Form S-3.S-3, the table lists each of the classes of securities being registered and the aggregate proceeds to be raised, but does not specify by each class information as to the amount to be registered, proposed maximum offering price per unit, and proposed maximum aggregate offering price.

 

(3)(4)                       Calculated pursuantThe proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act.  The registration fee was previously paid in connection with filing the initial registration statement on Form S-3.

(4)Each depositary share will represent an interest in a fractional shareAct of preferred stock and will be evidenced by a depositary receipt.1933.

 

(5)                       Each unit will represent an interestIncludes consideration to be received by us, if applicable, for registered securities that are issuable upon exercise, conversion or exchange of other registered securities.

(6)Consisting of some or all of the securities listed above, in two or more other securities, which may or may not be separable from one another.any combination, including common stock, preferred stock and warrants.

 


 

The Registrantregistrant hereby amends this Registration Statementregistration statement on such date or dates as may be necessary to delay its effective date until the Registrantregistrant shall file a further amendment which specifically states that this Registration Statementregistration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statementregistration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), shallmay determine.

 

 

 



Table of Contents

 

The information in this prospectus is not complete and may be changed.  We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective.  This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

Subject to completion, dated February 2, 2010August 22, 2014

 

PROSPECTUS

 

Summer Infant, Inc.

 

$100,000,00030,000,000

Common Stock

Preferred Stock

Warrants

Purchase ContractsDebt Securities

Depositary Shares

Subscription Rights

Units

 


 

This prospectus relates to common stock, preferred stock, warrants, purchase contracts, depositary shares, rightsWe may offer and units that we may sell from time to time, in one or more offeringstransactions, common stock, preferred stock, warrants, debt securities, subscription rights and units that include any of these securities, up to a total dollar amountpublic offering price of $100,000,000$30,000,000 on terms to be determined at the time of sale.  We will provide specific terms of these securities in supplements to this prospectus.  You should read this prospectus and any supplement carefully before you invest.  This prospectus may not be used to offer and sell securities unless accompanied by a prospectus supplement for those securities.

 

Our common stock is traded on the Nasdaq Capital Market under the symbol “SUMR.”

TheseWe may offer and sell these securities may be sold directly by us, through dealers or agents designated from time to time,investors, to or through one or more underwriters, dealers and agents, or through a combination of these methods. Seemethods, on a continuous or delayed basis.  For more information, see “Plan of Distribution” in this prospectus.  We may also describe the plan of distribution for any particular offering of these securities in any applicablea prospectus supplement.  If any agents, underwriters, dealers or dealersagents are involved in the sale of any securities in respect of which this prospectus is being delivered, we will disclose their names and the nature of our arrangements with them in a prospectus supplement.  The price to the public of such securities and the net proceeds we expect to receive from any such sale will also be includedset forth in a prospectus supplement.

This prospectus describes some of the general terms that may apply to these securities and the general manner in which they may be offered.  Each time we sell securities we will provide a prospectus supplement that will contain specific information about the terms of the securities we are offering and the specific manner in which we will offer the securities.  You should read this prospectus and each applicable prospectus supplement carefully before you invest.

Our common stock is listed on The NASDAQ Capital Market under the symbol “SUMR.”

As of August 15, 2014, the aggregate market value of the voting and non-voting common equity held by non-affiliates, computed by reference to the price at which the common equity was last sold or the average bid and asked price of such common equity on that date, was approximately $41,343,533, based on 18,107,082 shares of outstanding common stock, of which 7,169,560 were held by non-affiliates.  Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding more than one-third of our public float in any 12-



Table of Contents

month period so long as our public float remains below $75.0 million.  We have not offered any securities pursuant to General Instruction I.B.6 of Form S-3 during the 12 calendar months prior to and including the date of this prospectus.

 


 

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 1.2 of this prospectus.  We may include additional risk factors in an applicable prospectus supplement under the heading “Risk Factors.”  You should review that section of the prospectus supplement for a discussion of matters that investors in our securities should consider.

 




Table of Contents

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined ifpassed upon the adequacy or accuracy of this prospectus is truthful or complete.prospectus. Any representation to the contrary is a criminal offense.

 


 

The date of this prospectus is                     , 20102014.

 



Table of Contents

 

TABLE OF CONTENTS

 

 

Page

 

 

About this Prospectus

1

About Summer Infant, Inc.Special Note Regarding Forward-Looking Statements

1

Risk Factors

12

Special Note Regarding Forward-Looking InformationAbout Summer Infant, Inc.

2

Use of Proceeds

3

TheDescription of Securities We May Offer

3

Description of CommonCapital Stock

4

Description of Preferred StockWarrants

59

Description of Depositary Shares

7

Description of Warrants

11

Description of Purchase ContractsDebt Securities

12

Description of Subscription Rights

1323

Description of Units

14

Certain Anti-Takeover and Indemnification Provisions of our Certificate of Incorporation and Bylaws and Delaware Law

1524

Plan of Distribution

1925

Experts

2128

Legal Matters

2128

Where You Can Find More Information

2228

Incorporation of Certain DocumentsInformation By Reference

2228

 

Important Notice about the Information Presented in this Prospectus

You should rely only on the information contained in this prospectus, any prospectus supplement or incorporated by referenceany document to which we have referred you.  We have not authorized anyone else to provide you with information that is different.  This prospectus and any prospectus supplement may be used only where it is legal to sell these securities.  The information in this prospectus or any applicable prospectus supplement. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. For further information, see the section of this prospectus entitled “Where You Can Find More Information.” We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.

You should not assume that the information appearing in this prospectus or any applicable prospectus supplement is accuratecurrent only as of any date other than the date on the front cover of this prospectus or the applicable prospectus supplement, or that the information contained in any document incorporated by reference is accurate as of any date other than the date of the document incorporated by reference, regardless of the time of delivery of this prospectus or any prospectus supplement or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since such dates.those documents.

 

i



Table of Contents

 

ABOUT THIS PROSPECTUS

 

This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a “shelf” registration process.  Under this shelf process, we may sell from time to time any combination of the securities described in this prospectus in one or more offerings up to a total dollar amountpublic offering price of $100,000,000.  $30,000,000.

This prospectus provides you with a general description of the securities we may offer.  Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the securities being offered and the terms of that offering.  The prospectus supplement may also add to, update or change information contained in this prospectus.  You should read both this prospectus and any prospectus supplement together with the additional information described under the heading “Where You Can Find More Information” carefully before making an investment decision.

 

Unless the context otherwise requires, the terms “Registrant,” “the Company,”in this prospectus, “Summer,” “our company,the “Company,” “we,” “us,” “our” and similar names refer collectively to Summer Infant, Inc.  and its subsidiaries.

 

ABOUT SUMMER INFANT, INC.

We are a designer, marketer, and distributor of branded juvenile health, safety and wellness products which are sold principally to large North American and UK retailers. We currently have more than 80 proprietary products in various product categories including nursery audio/video monitors, safety gates, durable bath products, bed rails, related health and safety products, booster and potty seats, bouncers, sleep positioners, head supports, portable changing pads, nursery and feeding accessories, and a product line of soft goods/bedding. Our products are sold primarily to U.S. retailers including Babies R Us, Target, KMart, Buy Buy Baby, Meijer, Baby Depot (Burlington Coat Factory) and Wal-Mart.

We maintain through Summer Infant Europe, Limited (“SIE”) a sales, marketing and distribution office in the United Kingdom, which services the United Kingdom and other parts of Europe. SIE’s largest customers are Mothercare, Toys R Us, Argos, and Tesco.

We maintain through Summer Infant Asia, Ltd. a product development, engineering and quality assurance office, which oversees the production of all product lines made in China.

In 2008, Summer Infant (USA), including international sales managed out of the U.S., accounted for approximately 90% of revenue, Summer Infant Canada, Ltd. accounted for approximately 4%, and SIE accounted for approximately 6%.

RISK FACTORS

Investing in our securities involves significant risks.  Please see the risk factors under the heading “Risk Factors” in our most recent Annual Report on Form 10-K, as amended, as revised or supplemented by our Quarterly Reports on Form 10-Q, as amended, filed with the SEC since the filing of our most recent Annual Report on Form 10-K, each of which are on file with the SEC and are incorporated by reference in this prospectus.  Before making an investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus and any prospectus supplement.

1



Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATIONSTATEMENTS

 

This prospectus includes and incorporates forward-lookingany accompanying prospectus supplement (including any document incorporated by reference herein or therein) contain statements with respect to our Company which constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”).  We intend such forward-looking statementsand are intended to be covered by the safe harbor provisions forcreated by those sections.  Forward-looking statements, which are based on certain assumptions and reflect our plans, estimates and beliefs, can generally be identified by terms such as “expect,” “anticipate,” “believe,” “outlook,” “may,” “estimate,” “should,” “predict,” “intend,” “plan, “should” and similar terms or variations thereof.  These forward-looking statements containedinclude statements regarding our expected business strategy and future growth and profitability, our ability to leverage our retail knowledge and to deliver high quality, innovative products to the marketplace, our ability to maintain and build upon our existing customer and supplier relationships, and to grow our business, our ability to improve our operational efficiency, the fluctuation of market trends in the United States Private Securities Litigation Reform Actjuvenile products industry and our anticipated results of 1995.  Alloperations.  These statements are based on a series of expectations, assumptions, estimates and projections about our Company, are not guarantees of future results or performance, and involve significant risks, uncertainties and other than statements of historical facts, includedfactors, including assumptions and projections, for all forward periods.  Actual results may differ materially from any future results expressed or incorporated in this prospectus regarding our strategy, future operations, financial position, future revenues, projected costs, prospects, plans and objectives of management areimplied by such forward-looking statements.  The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we actually will achieveAmong the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. There are a number of important factors that could cause or contribute to these differences are those discussed under the heading “Risk Factors” and in other sections of (i) our actual resultsAnnual Report on Form 10-K for the year ended December 31, 2013, as amended, (ii) our other reports filed from time to differ materially from those indicated by these forward-looking statements. These important factors includetime with the factorsSEC that we identify in the documents we incorporateare incorporated by reference in this prospectus, as well as other information we include or incorporate by reference ininto this prospectus and any prospectus supplement.supplement and (iii) any prospectus supplement to this prospectus.  See “Risk Factors.”“Where You should readCan Find More Information” and “ Incorporation of Certain Information by Reference” for information about how to obtain copies of these factors and other cautionarydocuments.

All forward-looking statements made in this prospectus, and any accompanying prospectus supplement and in the documents we incorporate by reference as being applicable to all related forward-looking statements wherever they appear in the prospectus and any accompanying prospectus supplement, and in the documents incorporated by reference. We doreference therein are made only as of the date of the document in which they are contained, based on information available to us as of the date of that document, and we caution you not assume anyto place undue reliance on forward-looking statements in light of the risks and uncertainties associated with them.  Except as required by law, we undertake no obligation to update any forward-looking statements, madewhether as a result of new information, future events or otherwise.



Table of Contents

RISK FACTORS

An investment in our securities involves a high degree of risk.  The prospectus supplement applicable to each offering of our securities will contain a discussion of the risks applicable to an investment in Summer and to the particular types of securities that we are offering under that prospectus supplement.  Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the heading “Risk Factors” in the applicable prospectus supplement, together with all of the other information contained or incorporated by us.reference in the prospectus supplement or appearing or incorporated by reference in this prospectus.  You should also consider the risks, uncertainties and assumptions discussed under the heading “Risk Factors” included in our most recent Annual Report on Form 10-K, as revised or supplemented by our most recent Quarterly Report on Form 10-Q, each of which are on file with the SEC and are incorporated herein by reference, and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. Additional risks not presently known to us or that we currently believe to be immaterial may also adversely affect our business, operating results and financial condition and the value of an investment in our securities.

ABOUT SUMMER INFANT, INC.

Founded in 1985 and publicly traded on the Nasdaq Stock Market since 2007 under the symbol “SUMR,” we are a global designer, marketer, and distributor of branded juvenile health, safety and wellness products (for ages 0-3 years) that are sold principally to large North American and international retailers.  We currently market our products in the monitoring, health and safety, nursery, baby gear, feeding, and furniture product categories.  Most of our products are sold under our core brand names of Summer®, SwaddleMe® and Born Free®.

Our products are sold globally primarily to large, international retailers, and we also sell to independent retailers.  In North America, our customers include Babies R Us, Wal-Mart, Target, Amazon.com, Buy Buy Baby, Burlington Coat Factory, Kmart, Home Depot, and Lowe’s.  Our largest European based customers are Mothercare, Toys R Us, Argos and Tesco.  We also sell through several international representatives to select international retail customers in geographic locations where we do not have a direct sales presence.

Our principal executive offices are located at 1275 Park East Drive, Woonsocket, Rhode Island 02895, and our telephone number is (401) 671-6550.  Our website is www.summerinfant.com.  Information contained on our website or that can be accessed through our website is not incorporated by reference into this prospectus or any prospectus supplement and should not be considered to be part of this prospectus or any prospectus supplement.

 

2



Table of Contents

 

USE OF PROCEEDS

 

WeUnless otherwise indicated in the prospectus supplement, we currently intend to use the estimated net proceeds from the sale of these securities offered by this prospectus for working capital and other general corporate purposes, including, without limitation, repaying debt, and possibly, acquisitions of other businesses.companies or products.  Working capital and other general corporate purposes may include makingrepayment or repurchase of debt obligations, research and development expenditures, capital expenditures, funding generaloperating and administrative expensesexpenditures, and any other purpose that we may specify in any prospectus supplement.  While we have no current plans for any specific acquisitions at this time, we believe opportunities may exist from time to time to expand our current business through acquisitions of other companies or products.  We have not yet determined the amount of net proceeds to be used specifically for any of the foregoing purposes.  Accordingly, our management will have significantbroad discretion and flexibility in applying the net proceeds from the sale of these securities.  Pending any use as described above, we intend to invest the net proceeds in high-quality, short-term, interest-bearing securities.  Our plans to use the estimated net proceeds from the sale of these securities may change, and if they do, we will update this information in a prospectus supplement.

 

THEDESCRIPTION OF SECURITIES WE MAY OFFER

 

The descriptionsWe may issue from time to time, in one or more offerings the following securities:

·shares of common stock;

·shares of preferred stock;

·warrants exercisable for debt securities, common stock or preferred stock;

·debt securities;

·subscription rights to purchase any of such securities; and

·units of debt securities, common stock, preferred stock, rights or warrants, in any combination.

This prospectus contains a summary of the securities contained in this prospectus, together with the applicable prospectus supplements, summarize the material general terms and provisions of the various types of securities that we may offer.  We will describe in the applicable prospectus supplement relating to any securities the particularThe specific terms of the securities offered by that prospectus supplement.  If we so indicatewill be described in the applicablea prospectus supplement the terms of the securitiesor information incorporated by reference, which may differbe in addition to or different from the general terms we have summarized below.  We will also include in this prospectus.  Where applicable, the prospectus supplement or information where applicable, aboutincorporated by reference will also describe any material United States federal income tax considerations relating to the securities offered and indicate whether the securities exchange, if any, on which the securitiesoffered are or will be listed.listed on any securities exchange.  The summaries contained in this prospectus and in any prospectus supplements or information incorporated by reference may not contain all of the information that you would find useful.  Accordingly, you should read the actual documents relating to any securities sold pursuant to this prospectus.  See “Where You Can Find More Information” and “Incorporation of Certain Information by Reference” for information about how to obtain copies of those documents.

 

We may sell from timeThe terms of any particular offering, the initial offering price and the net proceeds to time,us will be contained in onethe prospectus supplement or more offerings:

·common stock;

·preferred stock;

·depositary shares;

·warrantsinformation incorporated by reference relating to purchase common stock, preferred stock, depositary shares or units;

·purchase contracts;

·rights to purchase common stock, preferred stock, depositary shares or warrants; or

·units comprised of common stock, preferred stock, depositary shares, warrants and purchase contracts in any combination.

In this prospectus, we refer to the common stock, preferred stock, depositary shares, warrants, purchase contracts, rights and units collectively as “securities.”  The total dollar amount of all securities that we may issue will not exceed $100,000,000.

This prospectus may not be used to consummate a sale of securities unless it is accompanied by a prospectus supplement.such offering.

 

3



Table of Contents

 

DESCRIPTION OF COMMONCAPITAL STOCK

 

General

The following is a description of our capital stock, together with the additional information included in any applicable prospectus supplement, summarizes the material terms and provisions of these types of securities but is not complete.  For the complete terms of our common stock. It may not contain all the information that is important to you. You can access complete information by referringcapital stock, please refer to our amendedAmended and restated certificateRestated Certificate of incorporation and bylaws, eachIncorporation, as amended to date (our “Certificate of Incorporation”) and our Amended and Restated Bylaws, as amended to date (our “Bylaws”), each of which is incorporated by reference into the registration statement of which this prospectus is a part.  We will describe in a prospectus supplement the specific terms of any common stock or preferred stock we refermay offer pursuant to as our “certificatethis prospectus.  If indicated in a prospectus supplement, the terms of incorporation” and “bylaws.”such common stock or preferred stock may differ from the terms described below.

 

General

WePursuant to our Certificate of Incorporation, we are a Delaware corporation.  Under our certificate of incorporation, we have authoritycurrently authorized to issue 100,000,00049,000,000 shares of common stock, par value $.0001$0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share.  As of December 10, 2009, there were 15,356,707 shares of common stock issued and outstanding.  All shares of common stock will, when issued, be dulyThe authorized fully paid and nonassessable.  Accordingly, the full price for the outstanding shares of common stock will have been paid at issuance and any holder of our common stock will not be later required to pay us any additional money for such common stock.

In addition, as of December 10, 2009:

·there were an aggregate of 2,009,600 shares of our common stock subjectand preferred stock will be available for issuance without further action by our stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded.  If the approval of our stockholders is not required, our board of directors may determine not to outstanding stock options at a weighted average exercise priceseek stockholder approval.  As of $3.70 per share;

·660,900August 15, 2014, 18,107,082 shares of our common stock were reserved for future issuances under the Summer Infant, Inc. 2006 Performance Equity Plan;issued and

·242,250 outstanding, and no shares of unvested restrictedpreferred stock are subject to outstanding awards.were issued and outstanding.

 

Common Stock

Dividends

 

Subject to provisions of the priorDelaware General Corporation Law, or the “DGCL,” and any future rights which may be granted to the holders of any series of preferred stock, which may from time to time be outstanding, the holders ofdividends are paid on our common stock are entitled to receive such dividends, if any,when and as may be declared from time to time by our board of directors out of funds legally available funds.  Infor dividend payments.

Voting Rights

Each holders of shares of our common stock is entitled to one vote per share on all matters submitted to the eventvote of our common stockholders.  Holders of our common stock are not entitled to cumulative voting rights.

Liquidation

If we are liquidated, dissolved or our affairs are wound up, after we pay or make adequate provision for allholders of our known debts and liabilities, each holder of common stock will receive dividends pro rata out of assets that we can legally use to pay distributions, subject to any rights that are granted to the holders of any class or series of preferred stock.

Voting Rights

Holders of common stock will have the exclusive power to vote on all matters presented to our stockholders, including the election of directors, except as otherwise provided by Delaware law or as provided with respect to any other class or series of stock.  Holders of common stock are entitled to one vote per share.  There is no cumulative voting in the electionreceive all remaining assets available for distribution to stockholders after satisfaction of our directors, which means that, subject to any rights to elect directors that are granted to the holders of any class or series of preferred stock, a plurality of the votes cast at a meeting of stockholders at which a quorum is present is sufficient to elect a director.

Other Rights

Subject toliabilities and the preferential rights of any other class or series of our preferred stock all sharesthat may be outstanding at that time.

Preemptive Rights

Holders of our common stock do not have equal dividend, distribution, liquidation and otherany preemptive, conversion or redemption rights and have no preference, appraisal or exchange rights, except for any appraisal rights provided by Delaware law.  Furthermore, holdersvirtue of their ownership of our common stock.

 

4



Table of Contents

 

common stock have no conversion, sinking fund or redemption rights, or preemptive rights to subscribe for any of our securities.

Transfer AgentPreferred Stock

 

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company.  Its address is 7 Battery Place, New York, New York 10004-1123.

Listing

Our common stock is listed on the Nasdaq Capital Market under the symbol “SUMR.”

DESCRIPTION OF PREFERRED STOCK

The following is a description of the material terms and provisions of our preferred stock. It may not contain all the information that is important to you. You can access complete information by referring to our certificate of incorporation and bylaws and to any applicable amendment to the certificate of incorporation designating terms of a series of preferred stock, including, without limitation, certificates of designation.

General

Under our certificate of incorporation, we have authority to issue 1,000,000 shares of preferred stock, par value $.0001 per share.

We do not have any shares of preferred stock outstanding as of the date of this prospectus.  Shares of preferred stock may be issued from time to time, in one or more series, as authorized byand our board of directors.  directors is authorized to determine the designation and fix the number of shares of each series.  Our board of directors is further authorized to fix and determine the dividend rate, premium or redemption rates, conversion rights, voting rights, preferences, privileges, restrictions and other rights granted to or imposed upon any wholly unissued series of our preferred stock.

Prior to the issuance of shares of eacha series theof our preferred stock, our board of directors, is required by the Delaware General Corporation Lawwithout stockholder approval, will adopt resolutions and ourfile a certificate of incorporation todesignation regarding the series of preferred stock with the State of Delaware and the SEC.  The certificate of designation will fix for each series the designations, powersdesignation and preferencesnumber of shares and the relative, participating, optional or other special rights, preferences, privileges and restrictions of the shares of each series and any qualifications, limitations and restrictions thereof, as are permitted by Delaware law.  Our board of directors could authorize the issuance of shares of preferred stock with terms and conditions that could have the effect of discouraging a takeover or other transactions that holders of common stock might believe to be in their best interests or in which holders of some, or a majority, of the shares of common stock might receive a premium for their shares over the then market price of such shares of common stock.  When issued, the preferred stock will be fully paid and nonassessable.

Terms

If we decide to issue any preferred stock pursuant to this prospectus, we will describe in a prospectus supplement the terms of the preferred stock, including if applicable, the following:

 

·                  the titlemaximum number of shares in the series and stated value;the designation;

·voting rights, if any, of the preferred stock;

 

·                  the numberdividend rates, periods and/or payment dates or methods of shares ofcalculation applicable to the series of preferred stock offered, the liquidation preference per share, if applicable, and the offering price;stock;

 

·                  the applicable dividend rate(s)whether dividends are cumulative or amount(s), period(s)non-cumulative, and payment date(s) or method(s) of calculation thereof;

5



Table of Contents

·if cumulative, the date from which dividends on the preferred stock will accumulate, if applicable;accumulate;

 

·                  any procedures for auctionthe relative ranking and remarketing;

·any provisions for a sinking fund;

·any applicable provision for redemption and the price or prices, terms and conditions on which preferred stock may be redeemed;

·any securities exchange listing;

·any voting rights and powers;

·whether interests inpreferences of the preferred stock will be represented by depository shares;as to dividend rights and rights upon liquidation, dissolution or winding up of our affairs;

 

·                  the terms and conditions, if applicable, of conversionupon which the preferred stock will be convertible into shares of our common stock, another series of preferred stock, or any other class of securities being registered hereby, including the conversion price or rate or(or manner of calculation thereof;

·a discussion of any material U.S. federal income tax considerations;calculation) and conversion period;

 

·                  the relative ranking and preference as to dividend rights and rights upon our provisions for redemption, if applicable, of the preferred stock;

·the provisions for a sinking fund, if any, for the preferred stock;

·liquidation dissolution or the winding up of our affairs;preferences;

 

·                  any limitationslimitation on the issuance of any class or series of preferred stock ranking senior to or on a parity with suchthe class or series of preferred stock as to dividend rights and rights upon our liquidation, dissolution or the winding up of our affairs; and

 

·                  any other specific terms, preferences, rights, limitations or restrictions of such series ofthe preferred stock.

 

6



Table of Contents

DESCRIPTION OF DEPOSITARY SHARES

We may issue receipts for depositary shares representing fractional shares of preferred stock.  The fractional shareThere shall be no limitation or restriction on any variation between any of the applicabledifferent series of preferred stock represented by each depositary share will be set forth inas to the applicable prospectus supplement.

designations, preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions thereof.  The shares of anyseveral series of preferred stock underlyingmay, except as otherwise expressly provided in any depositary shares that we may sell under this prospectus will be deposited under a deposit agreement between us and a depositary selected by us.  Subject to the terms of the deposit agreement, each holder of a depositary share will be entitled, in proportion to the applicable fraction of a share of the preferred stock underlying the depositary share, to all of the rights, preferences, and privileges, and will be subject to the qualifications and restrictions, of the preferred stock underlying that depositary share.

The depositary shares will be evidenced by depositary receipts issued under the deposit agreement.  Depositary receipts will be distributed to the holders of the depositary shares that are sold in the applicable offering.  We will incorporatesupplement or document incorporated by reference, intoas applicable, vary in any and all respects as fixed and determined by the registration statementresolution or resolutions of which this prospectus is a part the formour board of any deposit agreement, including a form of depositary receipt, that describes the terms of any depositary shares we are offering beforedirectors, providing for the issuance of the related depositary shares.  The following summaries of material provisions of the deposit agreement, the depositary shares, and the depositary receipts are subject to, and qualified in their entirety by reference to, all of the provisions of the deposit agreement applicable to a particular offering of depositary shares.  We urge you to read the prospectus supplements relating to any depositary shares that are sold under this prospectus, as well as the complete deposit agreement and depositary receipt.

Form

Pending the preparation of definitive depositary receipts, the depositary may, upon our written order, issue temporary depositary receipts substantially identical to the definitive depositary receipts but not in definitive form.  These temporary depositary receipts will entitle their holders to all of the rights of definitive depositary receipts.  Temporary depositary receipts will then be exchangeable for definitive depositary receipts at our expense.

Dividends and Other Distributions

The depositary will distribute all cash dividends or other cash distributions received with respect to the underlying preferred stock to the record holders of depositary shares in proportion to the number of depositary shares owned by those holders.

If there is a distribution other than in cash, the depositary will distribute property received by it to the record holders of depositary shares in proportion to the number of depositary shares owned by those holders, unless the depositary determines that it is not feasible to do so.  If this occurs, the depositary may, with our approval, sell the property and distribute the net proceeds from the sale to those holders in proportion to the number of depositary shares owned by them.

The amount distributed to holders of depositary shares will be reduced by any amounts required to be withheld by us or the preferred stock depositary on account of taxes or other governmental charges.

Liquidation Preference

If a series of preferred stock underlying the depositary shares has a liquidation preference, in the event of our voluntary or involuntary liquidation, dissolution, or winding up, holders of depositary sharesvarious series; provided, however,

 

75



Table of Contents

 

will be entitled to receive the fractionthat all shares of the liquidation preference accorded each share of the applicableany one series of preferred stock as set forth inshall have the applicable prospectus supplement.same designation, preferences and relative, participating, optional or other special rights and qualifications, limitations and restrictions.

 

Withdrawal of Underlying Preferred StockCertain Anti-Takeover Matters

 

Except as otherwise provided in a prospectus supplement, holders may surrender depositary receipts at the principal officeOur Certificate of the depositaryIncorporation and upon payment of any unpaid amount due to the depositary, be entitled to receive the number of whole shares of underlying preferred stock and all money and other property represented by the related depositary shares.  We will not issue any partial shares of preferred stock.  If the holder delivers depositary receipts evidencingBylaws include a number of depositary sharesprovisions that represent more than a whole numbermay have the effect of shares of preferred stock, the depositary will issue a new depositary receipt evidencing the excess number of depositary shares to the holder.

Redemption of Depositary Shares

If the preferred stock underlying any depositary shares we may sell under this prospectus is subject to redemption, the depositary shares will be redeemed from the proceeds received by the depositary resulting from any such redemption, in whole or in part, of that underlying preferred stock. The redemption price per depositary share will be equal to the applicable fraction of the redemption price per share payable with respect to the underlying preferred stock. Whenever we redeem shares of underlying preferred stock that are held by the depositary, the depositary will redeem, as of the same redemption date, the number of depositary shares representing the shares of underlying preferred stock so redeemed. If fewer than all of the depositary shares are to be redeemed, the depositary shares to be redeemed will be selected by lot or proportionately, as may be determined by the depositary.

After the date fixed for redemption, the depositary shares called for redemption will no longer be deemed to be outstanding, and all rights of the holders of the depositary shares will cease, except the right to receive the monies payable and any other property to which the holders were entitled upon the redemption upon surrender to the preferred stock depositary of the depositary receipts evidencing the depositary shares.  Any funds deposited by us with the preferred stock depositary for any depositary shares that the holders fail to redeem will be returned to us after a period of two years from the date the funds are deposited.

Voting

Upon receipt of notice of any meeting at which holders of the preferred stock underlying any depositary shares that we may sell under this prospectus are entitled to vote, the depositary will mail the information contained in the notice to the record holders of the depositary shares.  Each record holder of the depositary shares on the record date, which will be the same date as the record date for the underlying preferred stock, will be entitled to instruct the depositary as to the exercise of the voting rights pertaining to the amount of the underlying preferred stock represented by the holder’s depositary shares.  The depositary will then try, as far as practicable, to vote the number of shares of preferred stock underlying those depositary shares in accordance with those instructions, and we will agree to take all reasonable actions which may be deemed necessary by the depositary to enable the depositary to do so.  The depositary will not vote the underlying preferred stock to the extent it does not receive specific instructions with respect to the depositary shares representing such preferred stock.

Conversion of Preferred Stock

If the prospectus supplement relating to any depositary shares that we may sell under this prospectus states that the underlying preferred stock is convertible into our common stock or other

8



Table of Contents

securities, the following will apply.  The depositary shares, as such, will not be convertible into any of our securities.  Rather, any holder of the depositary shares may surrender the related depositary receipts to the depositary with written instructions that direct us to cause conversion of the preferred stock represented by the depositary shares into or for whole shares of our common stockencouraging persons considering unsolicited tender offers or other securities which will be issuedunilateral takeover proposals to the holder, as applicable.  Upon receipt of those instructions and any amounts payable by the holder in connection with the conversion, we will cause the conversion using the same procedures as those provided for conversion of the underlying preferred stock.  If only some of a holder’s depositary shares are converted, a new depositary receipt or receipts will be issued to the holder for any depositary shares not converted.

Amendment and Termination of the Deposit Agreement

The form of depositary receipt evidencing the depositary shares and any provision of the deposit agreement may at any time be amended by agreement between us and the depositary. However, any amendment which materially and adversely alters the rights of the holders of depositary shares will not be effective until 90 days after notice of that amendment has been given to the holders. Each holder of depositary shares at the time any amendment becomes effective shall be deemed to consent and agree to that amendment and to be bound by the deposit agreement as so amended. The deposit agreement may be terminated by us or by the depositary only if all outstanding depositary shares have been redeemed or converted into any other securities into which the underlying preferred stock is convertible or there has been a final distribution, including to holders of depositary receipts, of the underlying preferred stock in connectionnegotiate with our liquidation, dissolution, or winding up.

Chargesboard of Depositary

We will pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangement.  We will also pay charges of the depositary in connection with the initial deposit of the preferred stock, the initial issuance of the depositary shares, any redemption of the preferred stock, and all withdrawals of preferred stock by owners of depositary shares.  Holders of depositary receipts will pay transfer, income, and other taxes and governmental charges and other specified charges as provided in the deposit arrangement for their accounts.  If these charges have not been paid, the depositary may refuse to transfer depositary shares, withhold dividends and distributions, and sell the depositary shares evidenced by the depositary receipt.

Limitation on Liability

Neither we nor the depositary will be liable if either of us is prevented or delayed by law or any circumstance beyond our control in performing our respective obligations under the deposit agreement.  Our obligations and those of the depositary will be limited to performance of our respective duties under the deposit agreement without, in our case, negligence or bad faith or, in the case of the depositary, negligence or willful misconduct.  We and the depositary may rely upon advice of counsel or accountants, or upon information provided by persons presenting the underlying preferred stock for deposit, holders of depositary receipts, or other persons believed by us in good faith to be competent and on documents believed to be genuine.

Corporate Trust Office of Preferred Stock Depositary

The preferred stock depositary’s corporate trust office will be set forth in the applicable prospectus supplement relating to a series of depositary shares.  The preferred stock depositary will act as transfer agent and registrar for depositary receipts, and, if shares of a series of preferred stock are

9



Table of Contents

redeemable, the preferred stock depositary will act as redemption agent for the corresponding depositary receipts.

Resignation and Removal of Depositary

The depositary may resign at any time by delivering notice to us of its election to resign.  We may remove the depositary at any time.  Any resignation or removal will take effect upon the appointment of a successor depositary and its acceptance of the appointment.  The successor depositary must be appointed within 60 days after delivery of the notice of resignation or removal and must be a bank or trust company having its principal office in the United States and having a combined capital and surplus of at least $50,000,000.

Reports to Holders

We will deliver all required reports and communications to holders of the preferred stock to the preferred stock depositary, and it will forward those reports and communications to the holders of depositary shares. Upon request, the preferred stock depositary will provide for inspection to the holders of depositary shares the transfer books of the depositary and the list of holders of receipts; provided that any requesting holder certifies to the preferred stock depositary that such inspection is for a proper purpose reasonably related to such person’s interest as an owner of depositary shares evidenced by the receipts.

10



Table of Contents

DESCRIPTION OF WARRANTS

We may issue warrants for the purchase of common stock, preferred stock, depositary shares or units.  Warrants may be issued independently or together with common stock, preferred stock, depositary shares or units, and the warrants may be attached to or separate from such securities.  We may issue warrants directly or under a warrant agreement to be entered into between us and a warrant agent. We will name any warrant agent in the applicable prospectus supplement. Any warrant agent will act solely as our agent in connection with the warrants of a particular series and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants.

The following is a description of the general terms anddirectors rather than pursue non-negotiated takeover attempts.  These provisions of any warrants we may issue and may not contain all the information that is important to you. You can access complete information by referring to the applicable prospectus supplement. In the applicable prospectus supplement, we will describe the terms of the warrants and any applicable warrant agreement, including, where applicable,include the following:

 

·the offering price and aggregate number of warrants offered;

·the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security;

·the date on and after which the warrants and the related securities will be separately transferable;

·the number of shares of common stock, preferred stock, depositary shares or units, as the case may be, purchasable upon the exercise of one warrant and the price at which these securities may be purchased upon such exercise;

·the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;

·the terms of any rights to redeem or call the warrants;

·any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;

·the dates on which the right to exercise the warrants will commence and expire;

·the manner in which the warrant agreement and warrants may be modified;

·a discussion of any material U.S. federal income tax considerations;

·the terms of the securities issuable upon exercise of the warrants; and

·any other specific terms, preferences, rights or limitations of or restrictions on the warrants.

11



Table of Contents

DESCRIPTION OF PURCHASE CONTRACTS

We may issue purchase contracts, including contracts obligating holders to purchase from us, and for us to sell to holders, a specific or varying number of shares of common stock or preferred stock, depositary shares, warrants, or any combination of the above, at a future date or dates.  Alternatively, the purchase contracts may obligate us to purchase from holders, and obligate holders to sell to us, a specific or varying number of shares of common stock or preferred stock, depositary shares, warrants, or any combination of the above.  The price of the securities subject to the purchase contracts may be fixed at the time the purchase contracts are issued or may be determined by reference to a specific formula described in the purchase contracts.  We may issue purchase contracts separately or as a part of units, each consisting of a purchase contract and one or more of the other securities described in this prospectus or securities of third parties, including U.S. Treasury securities, securing the holder’s obligations under the purchase contract.  If we issue a purchase contract as part of a unit, the applicable prospectus supplement will state whether the purchase contract will be separable from the other securities in the unit before the purchase contract settlement date.  The purchase contracts may require us to make periodic payments to holders or vice versa and the payments may be unsecured or pre-funded on some basis.  The purchase contracts may require holders to secure the holder’s obligations in a manner specified in the applicable prospectus supplement, and in certain circumstances, we may deliver newly issued prepaid purchase contracts, often known as prepaid securities, upon release to a holder of any collateral securing such holder’s obligations under the original purchase contract.

The applicable prospectus supplement will describe the terms of any purchase contracts in respect of which this prospectus is being delivered, including, to the extent applicable, the following:

·whether the purchase contracts obligate the holder or us to purchase or sell, or both purchase and sell, the securities subject to purchase under the purchase contract, and the nature and amount of each of those securities, or the method of determining those amounts;

·whether the purchase contracts are to be prepaid or not;

·whether the purchase contracts will be issued as part of a unit and, if so, the other securities comprising the unit;

·whether the purchase contracts are to be settled by delivery, or by reference or linkage to the value, performance, or level of the securities subject to purchase under the purchase contract;

·a discussion of any material U.S. federal income tax considerations;

·any acceleration, cancellation, termination, or other provisions relating to the settlement of the purchase contracts; and

·whether the purchase contracts will be issued in fully registered or global form.

12



Table of Contents

DESCRIPTION OF RIGHTS

We may issue rights to purchase common stock, preferred stock, depositary shares warrants that we may offer to our securityholders.  The rights may or may not be transferable by the persons purchasing or receiving the rights.  In connection with any rights offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering.  Each series of rights will be issued under a separate rights agent agreement to be entered into between us and a bank or trust company, as rights agent, that we will name in the applicable prospectus supplement.  The rights agent will act solely as our agent in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights.

The prospectus supplement relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:

·the date of determining the security holders entitled to the rights distribution;

·the aggregate number of rights issued and the aggregate number of shares of common stock, preferred stock, depositary shares or warrants purchasable upon exercise of the rights;

·the exercise price;

·the conditions to completion of the rights offering;

·the date on which the right to exercise the rights will commence and the date on which the rights will expire; and

·a discussion of any material U.S. federal income tax considerations.

Each right would entitle the holder of the rights to purchase for cash the amount of shares of common stock, preferred stock, depositary shares or warrants at the exercise price set forth in the applicable prospectus supplement.  Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus supplement.  After the close of business on the expiration date, all unexercised rights will become void.

If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than our security holders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement.

13



Table of Contents

DESCRIPTION OF UNITS

The following description, together with the additional information we include in any applicable prospectus supplement, summarizes the material terms and provisions of the units that we may offer under this prospectus.  Units may be offered independently or together with common stock, preferred stock, depositary shares and/or warrants offered by any prospectus supplement, and may be attached to or separate from those securities.

While the terms we have summarized below will generally apply to any future units that we may offer under this prospectus, we will describe the particular terms of any series of units that we may offer in more detail in the applicable prospectus supplement.  The terms of any units offered under a prospectus supplement may differ from the terms described below.

We will incorporate by reference into the registration statement of which this prospectus is a part the form of unit agreement, including a form of unit certificate, if any, that describes the terms of the series of units we are offering before the issuance of the related series of units.  The following summaries of material provisions of the units and the unit agreements are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement applicable to a particular series of units.  We urge you to read the applicable prospectus supplements related to the units that we sell under this prospectus, as well as the complete unit agreements that contain the terms of the units.

General

We may issue units consisting of common stock, preferred stock, depositary shares, warrants, or any combination thereof.  Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit.  Thus, the holder of a unit will have the rights and obligations of a holder of each included security.  The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time, or at any time before a specified date.

We will describe in the applicable prospectus supplement the terms of the series of units, including the following:

·the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;

·a discussion of any material U.S. federal income tax considerations;

·any provisions of the governing unit agreement that differ from those described below; and

·any provisions for the issuance, payment, settlement, transfer, or exchange of the units or of the securities comprising the units.

The provisions described in this section, as well as those described under “Description of Common Stock,” “Description of Preferred Stock,” “Description of Depositary Shares,” “Description of Warrants,” “Description of Purchase Contracts” and “Description of Units” will apply to each unit and to any common stock, preferred stock, depositary share or warrant included in each unit, respectively.

14



Table of Contents

Issuance in Series

We may issue units in such amounts and in such numerous distinct series as we determine.

Enforceability of Rights by Holders of Units

A single bank or trust company may act as unit agent for more than one series of units.  Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any unit.  A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us.  Any holder of a unit, without the consent of the related unit agent or the holder of any other unit, may enforce by appropriate legal action its rights as holder under any security included in the unit.

Title

We, the unit agent, and any of their agents may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any purposes and as the person entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary.

CERTAIN ANTI-TAKEOVER AND INDEMNIFICATION PROVISIONS OF
OUR CERTIFICATE OF INCORPORATION AND BY-LAWS AND DELAWARE LAW

The following is a summary of certain anti-takeover and indemnification provisions of Delaware law and our certificate of incorporation and bylaws which affect us and our stockholders. The description below is intended as only a summary. You can access complete information by referring to Delaware General Corporation Law and our certificate of incorporation and bylaws, and the following summary is qualified in its entirety by reference to such documents and the applicable provisions of the Delaware General Corporation Law.

Advance Notice of Director Nominations and Stockholder ProposalsRequirements

 

Our by-lawsBylaws include advance notice, and informational requirements and time limitations on any director nomination or any new proposal which a stockholder wishes to make at an annual meeting of stockholders.  Detailed requirements as to the form of the notice and information required in the notice are specified in our Bylaws.  Generally, a stockholder’s notice of a director nomination or proposal will be timely if delivered to our corporate secretary at our principal executive offices not later than the close of business on the 60th day nor earlier than the close of business on the 90th day prior to the annual meeting.

Classified Board of Directors

Our board of directors  If it is divided into three classes serving staggered three-year terms. Our classified board, togetherdetermined that business was not properly brought before a meeting in accordance with certain otherthe provisions of our certificate of incorporation authorizingBylaws, such business will not be conducted at the board of directors to fill vacant directorships or increase the size of the board, may prevent a stockholder from removing, or delay the removal of, incumbent directors and simultaneously gaining control of the board of directors by filling vacancies created by such removal with its own nominees.meeting.

 

15



Table of Contents

Blank Check Preferred Stock

 

We have shares of preferred stock available for future issuance without stockholder approval.  The existence of authorized but unissued shares of preferred stock may enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.  For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of usthe Company or ourits stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificateCertificate of incorporationIncorporation grants our board of directors broad power to establish the rights and preferences of authorized and unissued shares of preferred stock.  The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of our common stock.  The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us.the Company.

 

Section 203Board Composition

Our board of directors is currently divided into classes serving staggered three-year terms, however, we recently amended our Certificate of Incorporation to declassify our board of directors over a three-year period, commencing at our 2014 annual meeting of stockholders.  Directors elected at our 2014 annual meeting of stockholders were elected to hold office for a term of one year (and not three years). As of our 2016 annual meeting of stockholders, our board of directors should be fully declassified and, thereafter, at each annual election of directors, all our directors of will be comprised of one class and all such directors will be elected on an annual basis.  Until the declassification process is completed, the classified board, together with certain other provisions of our Certificate of Incorporation authorizing the board of directors to fill vacant directorships or increase the size of the board, may prevent a stockholder from removing, or delay the removal of, incumbent directors and simultaneously gaining control of the board of directors by filling vacancies created by such removal with its own nominees.

6



Table of Contents

Amendments to Bylaws

Our board of directors is expressly authorized in our Certificate of Incorporation to alter or repeal our Bylaws, subject to the provisions of the Bylaws.  Our Bylaws may be amended by our board of directors, or by the affirmative vote of a majority of the outstanding shares of our common stock entitled to vote on the amendment.

Delaware General Corporation LawTakeover Statues

 

We are subject to the provisions of Section 203 of the Delaware General Corporation Law (“DGCL”).DGCL, an anti-takeover law.  In general, Section 203 prohibits a publicly heldpublicly-held, Delaware corporation from engaging in a “business combination”business combination with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder unless the business combination is approved infor a prescribed manner.  A “business combination” includes, among other things, a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder.  An “interested stockholder” is a person who, together with affiliates and associates, owns, or did own withinperiod of three years prior tofollowing the determination of interested stockholder status, 15% or more ofdate the corporation’s voting stock.  Under Section 203, a business combination between a corporation andperson became an interested stockholder, is prohibited unless it satisfies one of the following conditions:unless:

 

·                  beforePrior to the stockholder became interested,date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

 

·                  upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interestedThe stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stocknumber of shares outstanding (a) shares owned by persons who are directors and also officers, and (b) shares owned by employee stock plans in some instances;which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

 

·                  atOn or aftersubsequent to the timedate of the stockholder became interested,transaction, the business combination wasis approved by the board of directors of the corporation and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock whichthat is not owned by the interested stockholder.

 

TheGenerally, a business combination includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder.  An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own, 15% or more of a corporation’s outstanding voting securities.  We expect the existence of this provision mayto have an anti-takeover effect with respect to transactions our board of directors does not approve in advance.  We also anticipate that Section 203 may also discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.

 

These provisions of Delaware law, our Certificate of Incorporation and our certificate of incorporationBylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts.  These provisions may also have the effect of preventing changes in our

16



Table of Contents

management.  It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.

 

Indemnification7



Table of Directors and OfficersContents

Listing

 

Our common stock is listed on The NASDAQ Capital Market and trades under the symbol “SUMR.”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company.

8



Table of Contents

DESCRIPTION OF WARRANTS

General

We may issue warrants to purchase common stock, preferred stock, debt securities or units, or any combination of these securities.  Warrants may be issued independently or together with our common stock, preferred stock, debt securities or units, and may be attached to, or separate from, any offered securities.  We may also issue a series of warrants under a separate warrant agreement to be entered into between us and a warrant agent.  The warrant agent will act solely as our agent in connection with the warrants of such series and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants.

The following description is a summary of selected provisions relating to the warrants that we may issue. The summary is not complete.  When warrants are offered in the future, a prospectus supplement, information incorporated by reference or free writing prospectus as applicable, will explain the particular terms of those securities and the extent to which these general provisions may apply.  The specific terms of the warrants as described in a prospectus supplement information or incorporated by reference will supplement and, if applicable, may modify or replace the general terms described in this section.

This summary and any description of warrants in the applicable prospectus supplement or information incorporated by reference is subject to and is qualified in its entirety by reference to all the provisions of any specific warrant document or agreement, which we will file with the SEC for incorporation by reference into this prospectus.  See “Where You Can Find More Information” and “Incorporation of Certain Information by Reference” for information on how to obtain a copy of a warrant document when it is filed.

When we refer to a series of warrants, we mean all warrants issued as part of the same series under the applicable warrant agreement.

Terms

The applicable prospectus supplement or information incorporated by reference may describe the terms of any warrants that we may offer, including but not limited to the following:

·the title of the warrants;

·the total number of warrants;

·the price or prices at which the warrants will be issued;

·the date on which the right to exercise the warrants will commence and the date on which the right will expire;

·whether the warrants will be issued in registered form or bearer form;

·information with respect to book-entry procedures, if any;

·if applicable, the minimum or maximum amount of warrants that may be exercised at any one time;

·if applicable, the designation and terms of the underlying securities with which the warrants are issued and the number of warrants issued with each underlying security;

9



Table of Contents

·if applicable, the date on and after which the warrants and the related underlying securities will be separately transferable;

·if applicable, a discussion of material United States federal income tax considerations;

·if applicable, the terms of redemption of the warrants;

·the identity of the warrant agent, if any;

·the procedures and conditions relating to the exercise of the warrants; and

·any other terms of the warrants, including terms, procedures, and limitations relating to the exchange and exercise of the warrants.

Warrant Agreements

We may issue the warrants in one or more series under one or more warrant agreements, each to be entered into between us and a bank, trust company, or other financial institution as warrant agent.  We may add, replace, or terminate warrant agents from time to time.  We may also choose to act as our own warrant agent, or may choose one of our subsidiaries to do so.

The warrant agent under a warrant agreement will act solely as our agent in connection with the warrants issued under that agreement.  The warrant agent will not assume any obligation or relationship of agency or trust for or with any holders of those warrants.  Any holder of warrants may, without the consent of any other person, enforce by appropriate legal action, on its own behalf, its right to exercise those warrants in accordance with their terms.  Until the warrant is properly exercised, no holder of any warrant will be entitled to any rights of a holder of the warrant property purchasable upon exercise of the warrant.

Form, Exchange, and Transfer

We may issue the warrants in registered form or bearer form.  Warrants issued in registered form, i.e., book-entry form, will be represented by a global security registered in the name of a depository, which will be the holder of all the warrants represented by the global security.  Those investors who own beneficial interests in a global warrant will do so through participants in the depository’s system, and the rights of these indirect owners will be governed solely by the applicable procedures of the depository and its participants.  In addition, we may issue warrants in non-global form, i.e., bearer form.  If any warrants are issued in non-global form, warrant certificates may be exchanged for new warrant certificates of different denominations, and holders may exchange, transfer, or exercise their warrants at the warrant agent’s office or any other office indicated in the applicable prospectus supplement, information incorporate by reference or free writing prospectus.

Prior to the exercise of their warrants, holders of warrants exercisable for debt securities will not have any of the rights of holders of the debt securities purchasable upon such exercise and will not be entitled to payments of principal (or premium, if any) or interest, if any, on the debt securities purchasable upon such exercise.  Prior to the exercise of their warrants, holders of warrants exercisable for shares of preferred stock or common stock will not have any rights of holders of the preferred stock or common stock purchasable upon such exercise and will not be entitled to dividend payments, if any, or voting rights of the preferred stock or common stock purchasable upon such exercise.

10



Table of Contents

Exercise of Warrants

A warrant will entitle the holder to purchase an amount of securities at an exercise price that will be stated in, or that will be determinable as described in, the applicable prospectus supplement or information incorporated by reference.  Holders of warrants may exercise the warrants at any time up to the specified time on the expiration date set forth in the applicable prospectus supplement or information incorporated by reference. After the close of business on the expiration date, unexercised warrants will become void.  Warrants may be redeemed as set forth in the applicable prospectus supplement or information incorporated by reference.

Warrants may be exercised as set forth in the applicable prospectus supplement or information incorporated by reference.  Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of incorporationthe warrant agent or any other office indicated in the prospectus supplement or information incorporated by reference, we will forward, as soon as practicable, the securities purchasable upon such exercise.  If less than all of the warrants represented by such warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.

11



Table of Contents

DESCRIPTION OF DEBT SECURITIES

Our debt securities may be issued from time to time in one or more series and bylawsmay include senior debt securities, subordinated debt securities, convertible debt securities and exchangeable debt securities. The particular terms of any series of debt securities and the extent to which the general provisions may apply to a particular series of debt securities will be described in the prospectus supplement relating to that series.  When describing any debt securities, references to “we,” “us” and “our” refer to the issuer of those debt securities and not to any of its subsidiaries.

The debt securities we offer will be issued under an indenture between us and the trustee named in the indenture.  You should also read the indenture under which the debt securities are to be issued.  We have filed a form of indenture governing different types of debt securities with the SEC as an exhibit to the registration statement of which this prospectus is a part.  The following summary of the indenture does not purport to be complete and is subject to, and qualified in its entirety by reference to, all of the provisions of the indenture, including definitions therein of certain terms.  A form of each debt security, reflecting the specific terms and provisions of that series of debt securities, will be filed with the SEC in connection with each offering and will be incorporated by reference in the registration statement of which this prospectus forms a part.  You may obtain a copy of the indenture and any form of debt security that has been filed in the manner described under “Where You Can Find More Information.”

For a comprehensive description of any series of debt securities being offered to you pursuant to this prospectus, you should read this prospectus and the applicable prospectus supplement, indenture and form of debt security.

General Terms of the Indenture

The indenture does not limit the amount of debt securities that we may issue.  The indenture does provide that we will indemnify,may issue debt securities up to the fullest extent permittedprincipal amount that we may authorize, which may be in any currency or currency unit that we may designate.  Except for the limitations on consolidation, merger and sale of all or substantially all of our assets contained in the indenture, the terms of the indenture do not contain any covenants or other provisions designed to give holders of any debt securities protection against changes in our operations, financial condition or transactions involving us.  For each series of debt securities, any restrictive covenants for those debt securities will be described in the applicable prospectus supplement for those debt securities.

We may issue the debt securities issued under the indenture as “discount securities,” which means they may be sold at a discount below their stated principal amount.  These debt securities, as well as other debt securities that are not issued at a discount, may, for United States federal income tax purposes, be treated as if they were issued with “original issue discount,” or OID, because of interest payment and other characteristics.  Special United States federal income tax considerations applicable to debt securities issued with original issue discount will be described in more detail in any applicable prospectus supplement.

The prospectus supplement relating to a particular series of debt securities will describe the terms of the debt securities offered by that prospectus supplement and by this prospectus, including the following:

·the title and authorized denominations of the debt securities;

·any limit on the aggregate principal amount of that series of debt securities;

12



Table of Contents

·the date or dates on which principal and premium, if any, of the debt securities of that series is payable;

·interest rates, and the dates from which interest, if any, on the debt securities of that series will accrue, and the dates when interest is payable and the maturity;

·the right, if any, to extend the interest payment periods and the duration of the extensions;

·the guarantors, if any, of our obligations under the debt securities;

·if the amount of payments of principal or interest is to be determined by reference to an index or formula, or based on a coin or currency other than that in which the debt securities are stated to be payable, the manner in which these amounts are determined and the calculation agent, if any, with respect thereto;

·the place or places where and the manner in which principal of, premium, if any, and interest, if any, on the debt securities of that series will be payable and the place or places where those debt securities may be presented for transfer and, if applicable, conversion or exchange;

·the period or periods within which, the price or prices at which, the currency or currencies in which, and other terms and conditions upon which those debt securities may be redeemed, in whole or in part, at our option or the option of a holder of those securities, if we or a holder is to have that option;

·our obligation or right, if any, to redeem, repay or purchase those debt securities pursuant to any sinking fund or analogous provision or at the option of a holder of those securities, and the terms and conditions upon which the debt securities will be redeemed, repaid or purchased, in whole or in part, pursuant to that obligation;

·the terms, if any, on which the debt securities of that series and any guarantees thereof will be subordinate in right and priority of payment to our other debt;

·the denominations in which those debt securities will be issuable;

·if other than the entire principal amount of the debt securities when issued, the portion of the principal amount payable upon acceleration of maturity as a result of a default on our obligations;

·whether those debt securities will be issued in fully registered form without coupons or in a form registered as to principal only with coupons or in bearer form with coupons;

·whether any securities of that series are to be issued in whole or in part in the form of one or more global securities and the depositary for those global securities;

·if other than United States dollars, the currency or currencies in which payment of principal of or any premium or interest on those debt securities will be payable;

·if the principal of or any premium or interest on the debt securities of that series is to be payable, or is to be payable at our election or the election of a holder of those securities, in securities or other property, the type and amount of those securities or

13



Table of Contents

other property, or the manner of determining that amount, and the period or periods within which, and the terms and conditions upon which, any such election may be made;

·the events of default and covenants relating to the debt securities that are in addition to, modify or delete those described in this prospectus;

·conversion or exchange provisions, if any, including conversion or exchange prices or rates and adjustments thereto;

·whether and upon what terms the debt securities may be defeased, if different from the provisions set forth in the indenture;

·the nature and terms of any security for any secured debt securities;

·the terms applicable to any debt securities issued at a discount from their stated principal amount; and

·any other specific terms of any debt securities.

The applicable prospectus supplement will present material United States federal income tax considerations for holders of any debt securities and the securities exchange or quotation system on which any debt securities are to be listed or quoted.

Conversion or Exchange Rights

Debt securities may be convertible into or exchangeable for shares of our common stock or other securities.  The terms and conditions of conversion or exchange will be stated in the applicable prospectus supplement.  The terms will include, among others, the following:

·the conversion or exchange price;

·the conversion or exchange period;

·provisions regarding our ability or the ability of any holder to convert or exchange the debt securities;

·events requiring adjustment to the conversion or exchange price; and

·provisions affecting conversion or exchange in the event of our redemption of the debt securities.

Consolidation, Merger or Sale

The terms of the indenture prevent us from consolidating or merging with or into, or conveying, transferring or leasing all or substantially all of our assets to, any person, unless (i) we are the surviving corporation or the successor corporation or person to which our assets are conveyed, transferred or leased is organized under the laws of the United States, any state of the United States or the District of Columbia and it expressly assumes our obligations under the debt securities and the indenture, and (ii) immediately after completing such a transaction, no event of default under the indenture, and no event that, after notice or lapse of time or both, would become an event of default under the indenture, has occurred and is

14



Table of Contents

continuing.  When the person to whom our assets are conveyed or transferred has assumed our obligations under the debt securities and the indenture, we will be discharged from all our obligations under the debt securities and the indenture except in limited circumstances.

This covenant would not apply to any recapitalization transaction, a change of control affecting us or a highly leveraged transaction, unless the transaction or change of control were structured to include a merger or consolidation or conveyance, transfer or lease of all or substantially all of our assets.

Events of Default

The indenture provides that the following will be “events of default” with respect to any series of debt securities:

·failure to pay interest for 30 days after the date payment is due and payable;

·failure to pay principal or premium, if any, on any debt security when due, either at maturity, upon any redemption, by declaration or otherwise;

·failure to make sinking fund payments when due and continuance of such default for a period of 30 days;

·failure to perform other covenants for 60 days after notice of such default or breach and request for it to be remedied;

·events in bankruptcy, insolvency or reorganization relating to us; or

·any other event of default provided in the applicable officer’s certificate, resolution of our board of directors or the supplemental indenture under which we issue a series of debt securities.

An event of default for a particular series of debt securities does not necessarily constitute an event of default for any other series of debt securities issued under the indenture.  For each series of debt securities, any modifications to the above events of default will be described in the applicable prospectus supplement for those debt securities.

The indenture provides that if an event of default specified in the first, second, third, fourth or sixth bullets above occurs and is continuing, either the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series may declare the principal amount of all those debt securities (or, in the case of discount securities or indexed securities, that portion of the principal amount as may be specified in the terms of that series) to be due and payable immediately. If an event of default specified in the fifth bullet above occurs and is continuing, then the principal amount of all those debt securities (or, in the case of discount securities or indexed securities, that portion of the principal amount as may be specified in the terms of that series) will be due and payable immediately, without any declaration or other act on the part of the trustee or any holder. In certain cases, the holders of a majority in principal amount of the outstanding debt securities of any series may, on behalf of holders of all those debt securities, waive any past default and consequences of such default.

The indenture imposes limitations on suits brought by holders of debt securities against us.  Except for actions for payment of overdue principal or interest, no holder of debt securities of any series may institute any action against us under the indenture unless:

15



Table of Contents

·the holder has previously given to the trustee written notice of a continuing default;

·the holders of at least 25% in principal amount of the outstanding debt securities of the affected series have requested that the trustee institute the action;

·the requesting holders have offered the trustee indemnity for the costs, expenses and liabilities that may be incurred by bringing the action;

·the trustee has not instituted the action within 60 days of the request and offer of indemnity; and

·the trustee has not received inconsistent direction by the DGCL, each director or officerholders of a majority in principal amount of the outstanding debt securities of the affected series.

We will be required to file annually with the trustee a certificate, signed by one of our company, whomofficers, stating whether or not the officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the indenture.

Discharge, Defeasance and Covenant Defeasance

We can discharge or decrease our obligations under the indenture as stated below.

We may discharge obligations to holders of any series of debt securities that have not already been delivered to the trustee for cancellation and that have either become due and payable or are by their terms to become due and payable, or are scheduled for redemption, within one year.  We may effect a discharge by irrevocably depositing with the trustee cash or government obligations denominated in the currency of the debt securities, as trust funds, in an amount certified to be enough to pay when due, whether at maturity, upon redemption or otherwise, the principal of, and any premium and interest on, the debt securities and any mandatory sinking fund payments.

Unless otherwise provided in the applicable prospectus supplement, we may also discharge certain of our obligations to holders of any series of debt securities at any time, which we refer to as defeasance.  We may also be released from the obligations imposed by certain covenants of outstanding series of debt securities and provisions of the indenture, and we may omit to comply with those covenants without creating an “Indemnitee.”  Such indemnification includes paymentevent of default under the indenture, which we refer to as covenant defeasance.  We may effect defeasance and covenant defeasance only if, among other things:

·we irrevocably deposit with the trustee cash or government obligations denominated in the currency of the debt securities, as trust funds, in an amount certified by a nationally recognized firm of independent certified accountants to be enough to pay at maturity, or upon redemption, the principal (including any mandatory sinking fund payments) of, and any premium and interest on, all outstanding debt securities of the series; and

·we deliver to the trustee an opinion of counsel to the effect that the holders of the series of debt securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the defeasance or covenant defeasance and that defeasance or covenant defeasance will not otherwise alter the holders’ U.S. federal income tax treatment of principal, and any premium and interest payments on, the series of debt securities.

16



Table of Contents

In the case of a defeasance by us, in advancethe opinion we deliver must be based on a ruling of the final dispositionInternal Revenue Service issued, or a change in U.S. federal income tax law occurring, after the date of a civilthe indenture.

Although we may discharge or criminal action, suit,decrease our obligations under the indenture as described in the preceding paragraphs, we may not discharge certain enumerated obligations, including but not limited to, our duty to register the transfer or proceeding,exchange of expenses incurredany series of debt securities, to replace any temporary, mutilated, destroyed, lost or stolen series of debt securities or to maintain an office or agency in respect of any series of debt securities.

Modification of the Indenture

The indenture provides that we and the trustee may enter into supplemental indentures without the consent of the holders of debt securities to, among other things:

·evidence the assumption by a directorsuccessor entity of our obligations;

·add to our covenants for the benefit of the holders of debt securities, or officerto surrender any rights or power conferred upon us;

·add any additional events of default;

·cure any ambiguity or correct any inconsistency or defect in defending such action, suit, or proceeding upon receiptthe indenture provided that it does not adversely affect the interests of the holders of any undertaking by or on behalf of such director or officer to repay such payment if it is ultimately determined that he or she is not entitled to be indemnified by us.outstanding debt securities in any material respect;

 

Section 145·add to, change or eliminate any of the DGCL empowers a Delaware corporation to indemnify any persons who are, or are threatened to be made, parties to any threatened, pending or completed legal action, suit or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in the right of such corporation), by reasonprovisions of the fact that such person was an officer or director of such corporation, or is or was serving at the request of such corporation as a director, officer, employee, or agent of another corporation or enterprise.  The indemnity may include expenses (including attorneys’ fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit, or proceeding, provided that such officer or director acted in good faith andindenture in a manner he reasonably believed to be in or not opposedthat will become effective only when there is no outstanding debt security which is entitled to the corporation’s bestbenefit of the provision as to which the modification would apply;

·add guarantees to or secure any debt securities;

·establish the forms or terms of debt securities of any series;

·evidence and provide for the acceptance of appointment by a successor trustee and add to or change any of the provisions of the indenture as is necessary for the administration of the trusts by more than one trustee;

·add to or change any provision of the indenture as is necessary to permit or facilitate the issuance of debt securities in bearer form;

·change the location of (i) payment of principal, premium or interest; (ii) surrender of the debt securities for registration, transfer or exchange and (iii) notices and demands to or upon us;

·supplement any provision of the indenture to permit or facilitate the defeasance and discharge of any debt securities provided that it does not adversely affect the interests and, for criminal proceedings, had no reasonable causeof the holders of any outstanding debt securities in any material respect;

·conform the terms of any debt securities to believe his conduct was illegal.  A Delaware corporation may indemnify officers and directors in an action by orthe description of such debt securities in the right ofprospectus and prospectus supplement offering the corporation under the same conditions, exceptdebt securities provided that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation in the performance of his duty.  Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him against the expenses which such officer or director actually and reasonably incurred.

Under Delaware law, to the extent that an Indemnitee is successful on the merits in defense of a suit or proceeding brought against him or her by reason of the fact that he or she is or was a director, officer, or agent of our company, or serves or served any other enterprise or organization at the request of our company, we shall indemnify him or her against expenses (including attorneys’ fees) actually and reasonably incurred in connection with such action.

If unsuccessful in defense of a third-party civil suit or a criminal suit, or if such a suit is settled, an Indemnitee may be indemnified under Delaware law against both (i) expenses, including attorney’s fees, and (ii) judgments, fines, and amounts paid in settlement if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of our company, and, with respect to any criminal action, had no reasonable cause to believe his or her conduct was unlawful.

If unsuccessful in defense of a suit brought by or in the right of our company, where the suit is settled, an Indemnitee may be indemnified under Delaware law only against expenses (including attorneys’ fees) actually and reasonably incurred in the defense or settlement of the suit if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of our company except that if the Indemnitee is adjudged to be liable for negligence or misconduct in the performance of his or her duty to our company, he or she cannot be made whole even for expenses unless a court determines that he or she is fully and reasonably entitled to indemnification for such expenses.

Also under Delaware law, expenses incurred by an officer or director in defending a civil or criminal action, suit, or proceeding may be paid by our company in advance of the final disposition of the suit, action, or proceeding upon receipt of an undertaking by or on behalf of the officer or director to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by our

 

17



Table of Contents

 

company.  does not adversely affect the interests of the holders of any outstanding debt securities in any material respect;

·eliminate any provision that was required at the time we entered into the indenture but, as a result of an amendment to the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”), is no longer required;

·modify, eliminate or add to the provisions of the indenture to effect or evidence any change required by an amendment to the Trust Indenture Act; and

·make any other provisions with respect to matters or questions arising under the indenture as long as the new provisions do not adversely affect the interests of the holders of any outstanding debt securities of any series created prior to the modification in any material respect.

Any provision of the indenture shall automatically be deemed to have been modified, eliminated or added to the extent required to be made as a result of an amendment to the Trust Indenture Act.

The indenture also provides that we and the trustee may, with the consent of the holders of not less than a majority in aggregate principal amount of debt securities of each series of debt securities affected by such supplemental indenture then outstanding, add any provisions to, or change in any manner, eliminate or modify in any way the provisions of, the indenture or any supplemental indenture or modify in any manner the rights of the holders of the debt securities.  We and the trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:

·extend the final maturity of any debt security;

·reduce the principal amount or premium, if any;

·reduce the rate or extend the time of payment of interest;

·change the method of calculating the rate of interest in a manner adverse to the holders of any outstanding debt securities;

·reduce the amount of the principal of any debt security issued with an original issue discount that is payable upon acceleration;

·change the currency in which the principal, and any premium or interest, is payable;

·impair the right to institute suit for the enforcement of any payment on any debt security when due;

·if applicable, adversely affect the right of a holder to convert or exchange a debt security; or

·reduce the percentage of holders of debt securities of any series whose consent is required for any modification of the indenture or for waivers of compliance with or defaults under the indenture with respect to debt securities of that series.

The indenture provides that the holders of not less than a majority in aggregate principal amount of the then outstanding debt securities of any series, by notice to the trustee, may on behalf of the holders of the debt securities of that series waive any default and its consequences under the indenture except:

18



Table of Contents

·a default in the payment of the principal of or premium or interest on any such debt security; or

·a default in respect of a covenant or provision of the indenture that cannot be modified or amended without the consent of the holder of each outstanding debt security of each series affected.

Registered Global Securities and Book Entry System

The debt securities of a series may be issued in whole or in part in book-entry form and may be represented by one or more fully registered global securities.  We will deposit any registered global securities with a depositary or with a nominee for a depositary identified in the applicable prospectus supplement or with its custodian and such global securities shall be registered in the name of such depositary or nominee.  In such case, we will issue one or more registered global securities denominated in an amount equal to the aggregate principal amount of all of the debt securities of the series to be issued and represented by such registered global security or securities.  This means that we will not issue certificates to each holder.

Unless and until it is exchanged in whole or in part for debt securities in definitive registered form, a registered global security may not be transferred except as a whole:

·by the depositary for the registered global security to its nominee;

·by a nominee of the depositary to the depositary or another nominee of the depositary; or

·by the depositary or its nominee to a successor of the depositary or a nominee of the successor.

The prospectus supplement relating to a series of debt securities will describe the specific terms of the depositary arrangement involving any portion of the series represented by a registered global security.  We anticipate that the following provisions will apply to all depositary arrangements for debt securities:

·ownership of beneficial interests in a registered global security will be limited to persons that have accounts with the depositary for such registered global security, these persons being referred to as “participants,” or persons that may hold interests through participants;

·upon the issuance of a registered global security, the depositary for the registered global security will credit, on its book-entry registration and transfer system, the participants’ accounts with the respective principal amounts of the debt securities represented by the registered global security beneficially owned by the participants;

·any dealers, underwriters or agents participating in the distribution of the debt securities will designate the accounts to be credited; and

·ownership of beneficial interest in the registered global security will be shown on, and the transfer of the ownership interest will be effected only through, records maintained by the depositary for the registered global security for interests of

19



Table of Contents

participants, and on the records of participants for interests of persons holding through participants.

The laws of some states may require that specified purchasers of securities take physical delivery of the securities in definitive form.  These laws may limit the ability of those persons to own, transfer or pledge beneficial interests in registered global securities.

So long as the depositary for a registered global security, or its nominee, is the registered owner of the registered global security, the depositary or such nominee, as the case may be, will be considered the sole owner or holder of the debt securities represented by the registered global security for all purposes under the indenture.  Except as stated below, owners of beneficial interests in a registered global security:

·will not be entitled to have the debt securities represented by a registered global security registered in their names;

·will not receive or be entitled to receive physical delivery of the debt securities in the definitive form; and

·will not be considered the owners or holders of the debt securities under the indenture.

Accordingly, each person owning a beneficial interest in a registered global security must rely on the procedures of the depositary for the registered global security and, if the person is not a participant, on the procedures of a participant through which the person owns its interest, to exercise any rights of a holder under the indenture.

We understand that under existing industry practices, if we request any action of holders or if an owner of a beneficial interest in a registered global security desires to give or take any action that a holder is entitled to give or take under the indenture, the depositary for the registered global security would authorize the participants holding the relevant beneficial interests to give or take the action, and the participants would authorize beneficial owners owning through the participants to give or take the action or would otherwise act upon the instructions of beneficial owners holding through them.

We will make payments of principal and premium, if any, and interest, if any, on debt securities represented by a registered global security registered in the name of a depositary or its nominee to the depositary or its nominee, as the case may be, as the registered owners of the registered global security.

Neither we nor the trustee, or any other agent of ours or the trustee will be responsible or liable for any aspect of the records relating to, or payments made on account of, beneficial ownership interests in the registered global security or for maintaining, supervising or reviewing any records relating to the beneficial ownership interests.

We expect that the depositary for any debt securities represented by a registered global security, upon receipt of any payments of principal and premium, if any, and interest, if any, in respect of the registered global security, will immediately credit participants’ accounts with payments in amounts proportionate to their respective beneficial interests in the registered global security as shown on the records of the depositary.  We also expect that standing customer instructions and customary practices will govern payments by participants to owners of beneficial interests in the registered global security held through the participants, as is now the case with the securities held for the accounts of customers in

20



Table of Contents

bearer form or registered in “street name.”  We also expect that any of these payments will be the responsibility of the participants.

If the depositary for any debt securities represented by a registered global security is at any time unwilling or unable to continue as depositary, we will appoint an eligible successor depositary.  If we fail to appoint an eligible successor depositary within 90 days of such event, or if an event of default has occurred and is continuing and the holders of a majority in aggregate principal amount of the then outstanding debt securities of any series so request, we will issue the debt securities in definitive form in exchange for the registered global security.  In addition, we may at any time and in our sole discretion and subject to the depositary’s procedures decide not to have any of the debt securities of a series represented by one or more registered global securities.  In that event, we will issue debt securities of the series in a definitive form in exchange for all of the registered global securities representing the debt securities.  The trustee will register any debt securities issued in definitive form in exchange for a registered global security in the name or names as the depositary, based upon instructions from its participants, shall instruct the trustee.

We may also advance expenses incurredissue bearer debt securities of a series in the form of one or more global securities, referred to as “bearer global securities.”  We will deposit these securities with a depositary identified in the prospectus supplement relating to the series.  The prospectus supplement relating to a series of debt securities represented by other employees and agents of our company upon sucha bearer global security will describe the applicable terms and conditions, if any, that our board of directorsprocedures.  These will include the specific terms of the registrant deems appropriate.depositary arrangement and any specific procedures for the issuance of debt securities in definitive form in exchange for a bearer global security, in proportion to the series represented by a bearer global security.

 

Disclosure ofConcerning the SEC’s Position on Indemnification for Securities Act LiabilitiesTrustee

 

Insofar as indemnification by us for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the provisions referenced in Item 14 of this registration statement, or otherwise, we have been advisedThe indenture provides that in the opinionevent that the trustee resigns or is removed with respect to less than all series of debt securities outstanding under the indenture, there may be more than one trustee under the indenture.  If there are different trustees for different series of debt securities under the indenture, each such trustee will be a trustee of a trust under the indenture separate and apart from the trust administered by any other trustee under the indenture.  Except as otherwise indicated in this prospectus or any prospectus supplement, any action permitted to be taken by a trustee may be taken by such trustee only on the one or more series of debt securities for which it is the trustee under the indenture.  Any trustee under the indenture may resign or be removed from one or more series of debt securities.

The indenture provides that, except during the continuance of an event of default, the trustee will perform only such duties as are specifically set forth in the indenture.  During the existence of an event of default, the trustee will exercise those rights and powers vested in it under the indenture and use the same degree of care and skill in its exercise as a prudent person would exercise under the circumstances in the conduct of such person’s own affairs.

The trustee may engage in other transactions with us. If the trustee acquires any conflicting interest relating to any duties concerning the debt securities, however, the trustee must eliminate the conflict or resign as trustee.

No Individual Liability of Incorporators, Stockholders, Officers or Directors

The indenture provides that no past, present or future director, officer, stockholder or employee of ours, any of our affiliates, or any successor corporation, in their capacity as such, shall have any

21



Table of Contents

individual liability for any of our obligations, covenants or agreements under the debt securities or the indenture.

Governing Law

The indenture is, and any debt securities will be, governed by, and construed in accordance with, the laws of the Securities and Exchange Commission such indemnificationState of New York.

22



Table of Contents

DESCRIPTION OF SUBSCRIPTION RIGHTS

The following is against public policy as expresseda general description of the terms of the subscription rights we may issue from time to time.  Particular terms of any subscription rights we offer will be described in the Securities Actprospectus supplement relating to such subscription rights, and is, therefore, unenforceable.  Ifmay differ from the terms described herein.

We may issue subscription rights to purchase common stock, preferred stock, debt securities or warrants to purchase those securities.  These subscription rights may be issued independently or together with any other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a claimstandby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for indemnification againstafter such liabilities (other thanoffering.

The applicable prospectus supplement will describe the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defensespecific terms of any action, suitoffering of subscription rights for which this prospectus is being delivered, including the following:

·whether common stock, preferred stock, debt securities or proceeding) is assertedwarrants to purchase those securities will be offered under the stockholder subscription rights;

·the price, if any, for the subscription rights;

·the exercise price payable for each security upon the exercise of the subscription rights;

·the number of subscription rights issued to each stockholder;

·the number and terms of the securities which may be purchased per each subscription right;

·the extent to which the subscription rights are transferable;

·any other terms of the subscription rights, including the terms, procedures and limitations relating to the exchange and exercise of the subscription rights;

·the date on which the right to exercise the subscription rights shall commence, and the date on which the subscription rights shall expire;

·the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities;

·if appropriate, a discussion of material U.S. federal income tax considerations; and

·if applicable, the material terms of any standby underwriting or purchase arrangement entered into by a director, officer, or controlling personus in connection with the securities being registered hereunder, we will, unlessoffering of subscription rights.

The description in the opinionapplicable prospectus supplement of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act,any subscription rights we offer will not necessarily be complete and will be governedqualified in its entirety by reference to the final adjudication of such issue.applicable subscription rights certificate or subscription rights agreement, which will be filed with the SEC if we offer subscription rights.

 

1823



Table of Contents

DESCRIPTION OF UNITS

General

We may issue units consisting of common stock, preferred stock, debt securities or warrants, or any combination of these securities.  Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit.  As a result, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.

The following description is a summary of selected provisions relating to units that we may offer. The summary is not complete.  When units are offered in the future, a prospectus supplement or information incorporated by reference, as applicable, will explain the particular terms of those securities and the extent to which these general provisions may apply.  The specific terms of the units as described in a prospectus supplement or information incorporated by reference will supplement and, if applicable, may modify or replace the general terms described in this section.

This summary and any description of units in the applicable prospectus supplement or information incorporated by reference is subject to and is qualified in its entirety by reference to the unit agreement, collateral arrangements and depositary arrangements, if applicable.  We will file these documents with the SEC for incorporation by reference into this prospectus, as applicable.  See “Where You Can Find More Information” and “Incorporation of Certain Information by Reference” for information on how to obtain a copy of a document when it is filed.

We will describe in the applicable prospectus supplement or information incorporated by reference the terms of the series of units being offered, including:

·the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;

·any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units;

·whether the units will be issued in fully registered or global form; and

·any other terms of the units.

The applicable provisions described in this section, as well as those described under “Description of Capital Stock,” “Description of Warrants” and “Description of Debt Securities” will apply to each unit and to each security included in each unit, respectively.

24



Table of Contents

 

PLAN OF DISTRIBUTION

 

We may sell the securities being offered hereby in onethrough underwriters or more of the following ways from time to time:

·dealers, through agents, to the public or to investors;

·directly to one or more underwriterspurchasers, through rights offerings, or dealers for resale to the public or to investors;

·in “at the market offerings,” within the meaning of Rule 415(a)(4) of the Securities Act of 1933, as amended, to or through a market maker or into an existing trading market, or an exchange or otherwise;

·directly to investors in privately negotiated transactions; or

·through a combination of these methods of sale.

The securities that we distribute by any of these methods may be sold, in one or more transactions, at:

·a fixed price or prices, which may be changed;

·market prices prevailing at the time of sale;

·prices related to prevailing market prices; or

·negotiated prices.

otherwise.  We will set forth in a prospectus supplementdescribe the terms of the offering of ourthe securities in a prospectus supplement, information incorporated by reference or free writing prospectus, including:

 

·                  the name or names of any agents or underwriters;underwriters, if any;

 

·                  the purchase price of ourthe securities being offered and the proceeds we will receive from the sale;

 

·                  any over-allotment options under which underwriters may purchase additional securities from us;

·any agency fees or underwriting discounts and commissions and other items constituting agents’ or underwriters’ compensation;

 

·                  theany initial public offering price;

 

·                  any discounts or concessions allowed or reallowed or paid to dealers; and

 

·                  any securities exchangesexchange or market on which such common stockthe securities may be listed.

 

Only underwriters we name in the prospectus supplement, information incorporated by reference or free writing prospectus are underwriters of the securities offered thereby.

The distribution of securities may be effected, from time to time, in one or more transactions, including:

19·block transactions (which may involve crosses) and transactions on The NASDAQ Capital Market or any other organized market where the securities may be traded;

·purchases by a broker-dealer as principal and resale by the broker-dealer for its own account pursuant to a prospectus supplement;

·ordinary brokerage transactions and transactions in which a broker-dealer solicits purchasers;

·sales “at the market” to or through a market maker or into an existing trading market, on an exchange or otherwise; and

·sales in other ways not involving market makers or established trading markets, including direct sales to purchasers.

The securities may be sold at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices relating to the prevailing market prices or at negotiated prices.  The consideration may be cash or another form negotiated by the parties.  Agents, underwriters or broker-dealers may be paid compensation for offering and selling the securities.  That compensation may be in the form of discounts, concessions or commissions to be received from us or from the purchasers of the securities.  Dealers and agents participating in the distribution of the securities may be deemed to be underwriters, and compensation received by them on resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act.  If such dealers or agents were deemed to be underwriters, they may be subject to statutory liabilities under the Securities Act.

25



Table of Contents

 

UnderwritersWe may also make direct sales through subscription rights distributed to our existing stockholders on a pro rata basis, which may or may not be transferable.  In any distribution of subscription rights to our stockholders, if all of the underlying securities are not subscribed for, we may then sell the unsubscribed securities directly to third parties or may engage the services of one or more underwriters, dealers or agents, including standby underwriters, to sell the unsubscribed securities to third parties.  In addition, whether or not all of the underlying securities are subscribed for, we may concurrently offer additional securities to third parties directly or through underwriters, dealers or agents.

 

Underwriters, dealers and agents that participate in the distributionSome or all of the securities that we offer though this prospectus may be new issues of securities with no established trading market.  Any underwriters to whom we sell our securities for public offering and sale may make a market in those securities, but they will not be obligated to do so and they may discontinue any market making at any time without notice.  Accordingly, we cannot assure you of the liquidity of, or continued trading markets for, any securities that we offer.

In addition, we may enter into derivative or hedging transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions.  In connection with such a transaction, the third parties may sell securities covered by and pursuant to this prospectus and an applicable prospectus supplement or pricing supplement, as the case may be.  If so, the third party may use securities borrowed from us or others to settle such sales and may use securities received from us to close out any related short positions.  We may also loan or pledge securities covered by this prospectus and an applicable prospectus supplement to third parties, who may sell the loaned securities or, in an event of default in the case of a pledge, sell the pledged securities pursuant to this prospectus and the applicable prospectus supplement or pricing supplement, as the case may be.

Agents may, from time to time, solicit offers to purchase the securities.  If required, we will name in the applicable prospectus supplement, document incorporated by reference or free writing prospectus, as applicable, any agent involved in the offer or sale of the securities and set forth any compensation payable to the agent.  Unless otherwise indicated, any agent will be acting on a best efforts basis for the period of its appointment.  Any agent selling the securities covered by this prospectus may be deemed to be an underwriter, as that term is defined in the Securities Act, and any discounts or commissions they receive from us and any profit on their resale of the securities may be treated as underwriting discounts and commissions under the Securities Act.  We will identify in the applicable prospectus supplement any underwriters, dealers or agents and will describe their compensation. We may have agreements with the underwriters, dealers and agents to indemnify them against specified civil liabilities, including liabilities under the Securities Act.  Underwriters, dealers and agents may engage in transactions with or perform services for us or our subsidiaries in the ordinary course of their businesses.securities.

 

If we use underwriters for a sale ofare used in an offering, securities will be acquired by the underwriters will acquire the securities for their own account.  The underwritersaccount and may resell the securitiesbe resold, from time to time, in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale.sale, or under delayed delivery contracts or other contractual commitments.  Securities may be offered to the public either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters.  If an underwriter or underwriters are used in the sale of securities, an underwriting agreement will be executed with the underwriter or underwriters at the time an agreement for the sale is reached.  The obligationsapplicable prospectus supplement will set forth the managing underwriter or underwriters, as well as any other underwriter or underwriters, with respect to a particular underwritten offering of securities, and will set forth the terms of the transactions, including compensation of the underwriters and dealers and the public offering price, if applicable.  The prospectus, and the applicable prospectus supplement and any applicable free writing prospectus will be used by the underwriters to purchaseresell the securities.

If a dealer is used in the sale of the securities, we or an underwriter will be subjectsell the securities to the conditionsdealer, as principal.  The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.  To the extent required, we will set forth in the prospectus supplement, document incorporated by reference or free writing prospectus, as applicable, underwriting agreement.  The underwriters will be obligated to purchase all the securities offered if they purchase anyname of the securities offered. We may change from time to time any initial public offering price and any discounts or concessions the underwriters allow or reallow or pay to dealers.  We may use underwriters with whom we have a material relationship.  We will describe in the prospectus supplement naming the underwriters the nature of any such relationship.

If indicated in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit offers by particular institutions to purchase securities from us at the public offering price set forth in such prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on the date or dates stated in such prospectus supplement. Each delayed delivery contract will be for an amount no less than,dealer and the aggregate principal amounts of securities sold under delayed delivery contracts shall be not less nor more than, the respective amounts stated in the applicable prospectus supplement. Institutions with which such contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and others, but will in all cases be subject to our approval. The obligations of any purchaser under any such contract will be subject to the conditions that (a) the purchaseterms of the securities shall not at the time of delivery be prohibited under the laws of any jurisdiction in the United States to which the purchaser is subject, and (b) if the securities are being sold to underwriters, we shall have sold to the underwriters the total principal amount of the securities less the principal amount thereof covered by the contracts. The underwriters and such other agents will not have any responsibility in respect of the validity or performance of such contracts.

Agents

We may designate agents who agree to use their reasonable efforts to solicit purchases for the period of their appointment or to sell securities on a continuing basis.

Direct Sales

We may also sell securities directly to one or more purchasers without using underwriters or agents.

Trading Markets and Listing of Securities

Unless otherwise specified in the applicable prospectus supplement, each class or series of securities, other than our common stock, which is traded on the Nasdaq Capital Market, will be a new issue with no established trading market.  We may elect to list any other class or series of securities on any exchange, but we are not obligated to do so.  It is possible that one or more underwriters may make atransactions.

 

2026



Table of Contents

 

We may directly solicit offers to purchase the securities and may make sales of securities directly to institutional investors or others.  These persons may be deemed to be underwriters within the meaning of the Securities Act with respect to any resale of the securities.  To the extent required, the prospectus supplement, document incorporated by reference or free writing prospectus, as applicable, will describe the terms of any such sales, including the terms of any bidding or auction process, if used.

Agents, underwriters and dealers may be entitled under agreements which may be entered into with us to indemnification by us against specified liabilities, including liabilities incurred under the Securities Act, or to contribution by us to payments they may be required to make in respect of such liabilities.  If required, the prospectus supplement, document incorporated by reference or free writing prospectus, as applicable, will describe the terms and conditions of such indemnification or contribution. Some of the agents, underwriters or dealers, or their affiliates may be customers of, engage in transactions with or perform services for us, our subsidiaries or affiliates in the ordinary course of business.

Under the securities laws of some states, the securities offered by this prospectus may be sold in those states only through registered or licensed brokers or dealers.

Any person participating in the distribution of common stock registered under the registration statement that includes this prospectus will be subject to applicable provisions of the Exchange Act, and the applicable SEC rules and regulations, including, among others, Regulation M, which may limit the timing of purchases and sales of any of our common stock by any such person.  Furthermore, Regulation M may restrict the ability of any person engaged in the distribution of our common stock to engage in market-making activities with respect to our common stock.  These restrictions may affect the marketability of our common stock and the ability of any person or entity to engage in market-making activities with respect to our common stock.

Certain persons participating in an offering may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act that stabilize, maintain or otherwise affect the price of the offered securities.  If any such activities may occur, they will be described in the applicable prospectus supplement.

To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution.

All securities we offer other than common stock will be new issues of securities with no established trading market.  Any underwriters may make a market in a class or series ofthese securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice.  We cannot give any assurance as toguarantee the liquidity of the trading marketmarkets for any of the securities.

 

Stabilization Activities27



In connection with an offering, an underwriter may purchase and sell securities in the open market.  These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Shorts sales involve the sale by the underwritersTable of a greater number of securities than they are required to purchase in the offering.  “Covered” short sales are sales made in an amount not greater than the underwriters’ option to purchase additional securities from us, if any, in the offering.  If the underwriters have an over-allotment option to purchase additional securities from us, the underwriters may close out any covered short position by either exercising their over-allotment option or purchasing securities in the open market.  In determining the source of securities to close out the covered short position, the underwriters may consider, among other things, the price of securities available for purchase in the open market as compared to the price at which they may purchase securities through the over-allotment option.  “Naked” short sales are any sales in excess of such option or where the underwriters do not have an over-allotment option.  The underwriters must close out any naked short position by purchasing securities in the open market.  A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the securities in the open market after pricing that could adversely affect investors who purchase in the offering.

Accordingly, to cover these short sales positions or to otherwise stabilize or maintain the price of the securities, the underwriters may bid for or purchase securities in the open market and may impose penalty bids.  If penalty bids are imposed, selling concessions allowed to syndicate members or other broker-dealers participating in the offering are reclaimed if securities previously distributed in the offering are repurchased, whether in connection with stabilization transactions or otherwise.  The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market.  The impositions of a penalty bid may also effect the price of the securities to the extent that it discourages resale of the securities.  The magnitude or effect of any stabilization or other transactions is uncertain.  These transactions may be effected on the Nasdaq Capital Market or otherwise and, if commenced, may be discontinued at any time.Contents

 

EXPERTS

 

The consolidated financial statements of Summer Infant, Inc. includedincorporated in ourthis prospectus by reference to the Annual Report on Form 10-K as amended, for the year ended December 31, 2008,2013 have been audited by McGladrey & Pullen, LLP, an independent registered public accounting firm, as set forthstated in their report thereon, included therein, and incorporated herein by reference in this prospectusherein, and elsewhere in the registration statement.  Such consolidated financial statements arehas been so incorporated herein by reference in reliance upon such report given onand upon the authority of saidsuch firm as experts in accounting and auditing.

 

LEGAL MATTERS

 

Certain legal matters, including the legality of the securities offered, will be passed upon for us by our counsel, Greenberg Traurig, LLP, Boston, Massachusetts.  If the securities are distributed in an underwritten offering, certain legal matters will be passed upon for the underwriters by counsel identified in the applicable prospectus supplement.

 

21



Table of Contents

WHERE YOU CAN FIND MORE INFORMATION

 

We file annual, quarterly and current reports, proxy statements and other documentsinformation with the SEC.  You may read and copy any documentreports, statements or other information that we file at the SEC’s public reference room at 100 F Street, N.E., Room 1580, Washington, DCDistrict of Columbia 20549.  You shouldPlease call the SEC at 1-800-SEC-0330 for more information on the operation of the public reference room.  Our SEC filings are also available to you on the SEC’s Internet sitepublic from commercial retrieval services and at http://www.sec.gov.the website maintained by the SEC at www.sec.gov.  The SEC’s Internet site contains reports proxy and information statements, and other information regarding issuers that file electronicallyfiled by us with the SEC.

This prospectus is part of a registration statement that we filed with the SEC. The registration statement contains more information than this prospectus regarding us andSEC are also available at our common stock, including certain exhibits and schedules. You can obtain a copy of the registration statement from the SEC at the address listed above or from the SEC’s Internet site.

Our Internet address is www.summerinfant.com. The informationwebsite, www.summerinfant.com. Information contained on our Internetwebsite or that can be accessed through our website is not incorporated by reference ininto this prospectus.prospectus or any prospectus supplement and should not be considered to be part of this prospectus or any prospectus supplement.

 

INCORPORATION OF CERTAIN DOCUMENTSINFORMATION BY REFERENCE

 

The SEC allows us to “incorporate”incorporate information into this prospectus information that we file with the SEC in other documents. This“by reference,” which means that we can disclose important information to you by referring you to other documents that contain that information. Any informationanother document that we incorporatefile separately with the SEC.  The information incorporated by reference is considereddeemed to be part of this prospectus, except for any information superseded by information contained directly in this prospectus. TheThese documents contain important information about the Company and reportsits financial condition, business and results.

We are incorporating by reference the filings listed below and any additional documents that we list below are incorporated by reference into this prospectus (other than any portions of such documents that are not deemed “filed” under the Exchange Act in accordancemay file with the Exchange Act and applicable SEC rules). In addition, all documents and reports which we file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act on or after the date hereof and prior to the termination of this prospectusany offering, except we are incorporatednot incorporating by reference in this prospectus as of the respective filing dates of these documentsany information deemed to have been furnished and reports (other than any portions of such documents that are not deemed “filed” under the Exchange Actfiled in accordance with the Exchange Act and applicable SEC rules). Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information.

We have filed the following documents with the SEC. These documents are incorporated herein by reference as of their respective dates of filing:rules:

 

(1)·   ��       Ourour Annual Report on Form 10-K as amended, for the fiscal year ended December 31, 2008;

(2)Our Quarterly Reports on Form 10-Q, as amended, for the quarters ended March 31, 2009, June 30, 2009 and September 30, 2009;

(3)Our Current Reports on Form 8-K2013, filed with the SEC on March 27, 2009, May 27, 2009, July 16, 2009, August 5, 2009, November 2, 2009 and November 13, 2009;11, 2014, as amended on April 29, 2014;

 

(4)·                  Our Definitive Proxy Statementour Quarterly Report on Schedule 14AForm 10-Q for the quarter ended June 30, 2014, filed with the SEC on August 14, 2014;

·our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, filed with the SEC on May 11, 2009;13, 2014;

 

(5)Our Form 8-A filed with the SEC on March 6, 2007;

2228



Table of Contents

 

(6)·                  All of our filings pursuant toCurrent Reports on Form 8-K filed with the Exchange Act after the date of filing the initial registration statementSEC on January 17, 2014, May 15, 2014, May 27, 2014 and prior to the effectiveness of the registration statement;August 14, 2014; and

 

(7)·                  Thethe description of our common stock contained in our Registration Statement on Form 8-A filed on March 6, 2007, andincluding any amendments or reports filed for the purpose of updating thatthe description.

 

You may requestWe will provide, without charge, to each person, including any beneficial owner, to whom a copy of thesethis prospectus has been delivered a copy of any and all of the documents which will be providedreferred to you at no cost,herein that are incorporated by contacting:reference, if such person makes a written or oral request directed to:

 

Summer Infant, Inc.

Commission File No. 001-33346


1275 Park East Drive


Woonsocket, RIRhode Island 02895


Attn:  Corporate Secretary


(401) 671-6550

 

You should rely only on the information contained in this prospectus, including information incorporated by reference as described above, or any prospectus supplement that we have specifically referred you to. We have not authorized anyone else to provide you with different information. You should not assume that the information in this prospectus or any prospectus supplement is accurate as29



Table of any date other than the date on the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date. You should not consider this prospectus to be an offer or solicitation relating to the securities in any jurisdiction in which such an offer or solicitation relating to the securities is not authorized. Furthermore, you should not consider this prospectus to be an offer or solicitation relating to the securities if the person making the offer or solicitation is not qualified to do so, or if it is unlawful for you to receive such an offer or solicitation.Contents

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 14.                                                  Other Expenses of Issuance and Distribution.

 

The expenses in connection with the issuance and distribution of the securities being registered are set forth in the following table (all amounts except the registration fee are estimated):

 

SEC registration fee

 

$

5,580

 

Legal fees and expenses

 

$

20,000

 

Accounting fees and expenses

 

$

10,000

 

Printing fees and expenses

 

$

10,000

 

Transfer agent fees and expenses

 

$

5,000

 

Miscellaneous expenses

 

$

2,210

 

 

 

 

 

Total Expenses

 

$

52,790

 

SEC registration fee

 

$

3,864

 

NASDAQ Capital Market listing fee

 

*

 

Legal fees and expenses

 

*

 

Accounting fees and expenses

 

*

 

Printing expenses

 

*

 

Miscellaneous

 

*

 

 

 

 

 

Total

 

$

3,864

 

 

23



Table*These fees are calculated based on the securities offered and the number of Contentsissuances and, accordingly, cannot be estimated at this time.

 

Item 15.                                                  Indemnification of Directors and Officers.

 

Our certificate of incorporation and bylaws provide that we will indemnify,Pursuant to the fullest extent permitted by the DGCL, each director or officer of our company, whom we refer to as an “Indemnitee.”  Such indemnification includes payment by us, in advance of the final disposition of a civil or criminal action, suit, or proceeding, of expenses incurred by a director or officer in defending such action, suit, or proceeding upon receipt of any undertaking by or on behalf of such director or officer to repay such payment if it is ultimately determined that he or she is not entitled to be indemnified by us.

Section 145145(a) of the Delaware General Corporation Law (“DGCL”) empowers a Delaware corporation to, we may indemnify any personsperson who are,was or areis a party or is threatened to be made partiesa party to any threatened, pending or completed legal action, suit or proceeding whether civil, criminal, administrative, or investigative (other than an action by or in the right of suchthe corporation), by reason of the fact that suchthe person is or was ana director, officer, agent or directoremployee of such corporation,the Company or is or was serving at the Company’s request of such corporation as a director, officer, employee,agent, or agentemployee of another corporation, partnership, joint venture, trust or enterprise.  The indemnity may includeother enterprise, against expenses, (includingincluding attorneys’ fees), judgments,fees, judgment, fines and amounts paid in settlement actually and reasonably incurred by suchthe person in connection with such action, suit or proceeding.  Pursuant to Section 145(b) of the DGCL, the power to indemnify also applies to actions brought by or in the right of the corporation as well, but only to the extent of defense expenses (including attorneys’ fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit.  Pursuant to Section 145(b), the Company shall not indemnify any person in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Company unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.  The power to indemnify under Sections 145(a) and (b) of the DGCL applies (i) if such person is successful on the merits or otherwise in defense of any action, suit or proceeding, provided thator (ii) if such officer or directorperson acted in good faith and in a manner he reasonably believed to be in the best interest, or not opposed to the corporation’s best interests,interest, of the corporation, and forwith respect to any criminal proceedings,action or proceeding, had no reasonable cause to believe his conduct was illegal.unlawful.

Section 145(g) of the DGCL provides that a corporation shall have the power to purchase and maintain insurance on behalf of its officers, directors, employees and agents, against any liability asserted against and incurred by such persons in any such capacity.

II-1



Table of Contents

Section 174 of the DGCL provides, among other things, that a director, who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock purchase or redemption, may be held liable for such actions.  A Delaware corporationdirector who was either absent when the unlawful actions were approved or dissented at the time, may indemnify officers and directors in an actionavoid liability by causing his or her dissent to such actions to be entered in the rightbooks containing the minutes of the corporation undermeetings of the same conditions, exceptboard of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts.

Our Amended and Restated Certificate of Incorporation, as amended, provides that no indemnification is permitted without judicial approval if the officer ora director is adjudged toshall not be personally liable to the corporationCompany or its stockholders for monetary damages for breach of fiduciary duty except for: (a) any breach of the director’s duty of loyalty to the Company or its stockholders, (b) acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (c) under Section 174 of the performance of his duty.  WhereDGCL provisions imposing joint and several liability for improper distributions to stockholders or loans to officers or directors, or (d) transactions from which a director derived an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him against the expenses which such officer or director actually and reasonably incurred.improper personal benefit.

 

Under Delaware law,Our Amended and Restated Bylaws, as amended, require the Company to indemnify all officers, directors, employees and agents of the extent that an Indemnitee is successfulCompany against all liabilities and expenses they may incur on the merits in defenseaccount of a suitall actions threatened or proceeding brought against him or herthem by reason of their services to the fact that heCompany or she is or was a director, officer, or agent of our company, or serves or served any other enterprise or organizationto another entity at the request of our company, we shall indemnify him or her against expenses (including attorneys’ fees) actually and reasonably incurred in connection with such action.

If unsuccessful in defense of a third-party civil suit or a criminal suit, orthe Company if such a suit is settled, an Indemnitee may be indemnified under Delaware law against both (i) expenses, including attorney’s fees, and (ii) judgments, fines, and amounts paid in settlement if he or she actedmade in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of our company,the Company, and, with respect to any criminal action hador proceeding, with no reasonable cause to believe his or herthe conduct was unlawful.

 

If unsuccessfulOur directors and officers are covered by insurance policies maintained by the Company against specified liabilities for actions taken in defense of a suit brought by or in the right of our company, where the suit is settled, an Indemnitee may be indemnified under Delaware law only against expenses (including attorneys’ fees) actually and reasonably incurred in the defense or settlement of the suit if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of our company except that if the Indemnitee is adjudged to be liable for negligence or misconduct in the performance of his or her duty to our company, he or she cannot be made whole even for expenses unless a court determines that he or she is fully and reasonably entitled to indemnification fortheir capacities as such, expenses.

Also under Delaware law, expenses incurred by an officer or director in defending a civil or criminal action, suit, or proceeding may be paid by our company in advance of the final disposition of the suit, action, or proceeding upon receipt of an undertaking by or on behalf of the officer or director to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by our

24



Table of Contents

company.  We may also advance expenses incurred by other employees and agents of our company upon such terms and conditions, if any, that our board of directors of the registrant deems appropriate.

Reference is made to “Undertakings,” below, for the registrant’s undertakings in this registration statement with respect to indemnification ofincluding liabilities arising under the Securities Act of 1933, as amended.Act.  In addition, we have entered into indemnification agreements with our officers and directors that provide for indemnification and expense advancement to the fullest extent permitted under the Delaware General Corporation Law.

 

Item 16.                                                  Exhibits.

 

The exhibits listed in the Exhibit Index immediately preceding the exhibits are filed as part of this Registration Statement on Form S-3.

 

Item 17.                                                  Undertakings.

 

The undersigned Registrantregistrant hereby undertakes:

 

(1)                                 To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

 

(i)                                     To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

 

(ii)                                  To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement.  Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with

II-2



Table of Contents

the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; and

 

(iii)                               To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

 

provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrantregistrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference in this Registration Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the Registration Statement.

 

(2)                                 That, for the purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.

 

25



Table of Contents

(3)                                 To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(4)That, for the purpose of determining liability under the Securities Act to any purchaser:

 

(i)                                     If the Registrantregistrant is relying on Rule 430B:

 

(A) Each prospectus filed by the Registrantregistrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or

 

II-3



Table of Contents

(ii)                                  If the Registrantregistrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

(5)That, for the purpose of determining liability of the Registrantregistrant under the Securities Act to any purchaser in the initial distribution of the securities:

Thesecurities, the undersigned Registrantregistrant undertakes that in a primary offering of securities of such undersigned Registrantregistrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, such undersigned Registrantregistrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

26



Table of Contents

 

(i)                                     Any preliminary prospectus or prospectus of the undersigned Registrantregistrant relating to the offering required to be filed pursuant to Rule 424;

 

(ii)                                  Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrantregistrant or used or referred to by the undersigned Registrant;registrant;

 

(iii)                               The portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrantregistrant or its securities provided by or on behalf of the undersigned Registrant;registrant; and

 

(iv)                              Any other communication that is an offer in the offering made by the undersigned Registrantregistrant to the purchaser.

 

The undersigned Registrant hereby undertakes that,(6)That. for purposes of determining any liability under the Securities Act, each filing of the Registrant’sregistrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

Additionally, the undersigned registrant hereby undertakes to(7)To supplement the prospectus, after the expiration of the subscription period to set forth the results of the subscription offer, the transactions by the underwriters during the subscription period, the amount of unsubscribed securities to be purchased by the underwriters, and the terms of any subsequent reoffering thereof. If any public offering by the underwriters is to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective amendment will be filed to set forth the terms of such offering.

(8)To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act (“Act”) in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Act.

II-4



Table of Contents

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrantregistrant pursuant to the indemnification provisions described herein, or otherwise, the Registrantregistrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrantregistrant of expenses incurred or paid by a director, officer or controlling person of the Registrantregistrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrantregistrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

27II-5



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Woonsocket, State of Rhode Island, on this 2nd22nd day of February, 2010.August, 2014.

 

 

SUMMER INFANT, INC.

 

By:

 

 

By:

/s/ Jason MacariCarol E. Bramson

 

 

Jason MacariCarol E. Bramson

 

 

President and Chief Executive Officer and President

 

Each person whose signature appears below constitutes and appoints Carol E. Bramson and Paul Francese as his or her true and lawful agent, proxy and attorney-in-fact, each acting alone, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign, and file with the SEC any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment or any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act, and (iv) take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his or her substitutes may lawfully do or cause to be done by virtue thereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Jason MacariCarol E. Bramson

 

President, Chief Executive Officer and Director

 

August 22, 2014

Jason MacariCarol E. Bramson

 

Chief Executive Officer, President and Chairman of the Board of Directors
(Principal Executive Officer)

 

February 2, 2010

 

 

 

 

 

/s/ Joseph Driscoll

Joseph DriscollPaul Francese

 

Chief Financial Officer

August 22, 2014

Paul Francese

(Principal Financial and Accounting Officer)

 

February 2, 2010

 

 

 

 

 

*/s/ Dan Almagor

Chairman of the Board

August 22, 2014

Dan Almagor

 

 

 

 

Richard Wenz

Director

February 2, 2010

 

 

 

 

 

*

Steven Gibree

Director

February 2, 2010

*

 

 

 

 

Martin Fogelman

 

Director

 

February 2, 2010August 22, 2014

 

 

 

 

 

*/s/ Jason Macari

Director

August 22, 2014

Jason Macari

 

 

 

 

/s/ Derial Sanders

Director

August 22, 2014

Derial Sanders

/s/ Robert Stebenne

 

Director

 

February 2, 2010August 22, 2014

*By:Robert Stebenne

/s/ Joseph Driscoll

 

 

Joseph Driscoll

/s/ Richard Wenz

Director

August 22, 2014

Richard Wenz

 

 

Attorney-in-Fact

/s/ Stephen Zelkowicz

Director

August 22, 2014

Stephen Zelkowicz

 

 

28II-6



Table of Contents

 

EXHIBIT INDEX

 

EXHIBIT
NUMBER

 

DESCRIPTION

 

 

 

**1.1

 

Form of Underwriting Agreement Placement Agency Agreement, Dealer-Manager Agreement, Distribution Agreement or similar agreement.

 

 

 

3.1

 

Amended and Restated Certificate of Incorporation of the Company, (Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-A filed on March 6, 2007).2007, SEC File No. 001-33346)

 

 

 

3.2

 

By-LawsCertificate of the Company (IncorporatedAmendment to Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on June 7, 2010)

3.3

Certificate of Amendment to Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q filed on August 14, 2014)

3.4

Amended and Restated Bylaws (Incorporated by reference to Exhibit 3.3 to the Registrant’s Annual Report on Form 10-K filed on March 13, 2013)

4.1

Specimen Common Stock Certificate (Incorporated by reference to Exhibit 4.2 to the Registrant’s Form 8-A filed on March 6, 2007).2007, SEC File No. 001-33346)

 

 

 

**4.1

Form of Common Stock Warrant Agreement.

**4.2

 

Form of Preferred Stock Warrant Agreement.Indenture (including Form of Debt Security)

 

 

 

**4.3

 

Form of Certificate of Designation for Preferred Stock Issued Hereunder.

 

 

 

**4.4

 

Form of Depositary Receipt for Depositary Shares.Preferred Stock Certificate

 

 

 

**4.5

 

Form of DepositWarrant Agreement for Depositary Shares.(including Form of Warrant Certificate) with respect to Warrants to purchase Debt Securities

 

 

 

**4.6

 

Form of Purchase Contract.Warrant Agreement (including Form of Warrant Certificate) with respect to Warrants to purchase Common Stock

 

 

 

**4.7

 

Form of UnitWarrant Agreement and Unit Certificate.(including Form of Warrant Certificate) with respect to Warrants to purchase Preferred Stock

 

 

 

**4.8

 

Form of Rights AgentWarrant Agreement or Subscription Agent Agreement.(including Form of Warrant Certificate) with respect to Warrants to purchase Units

 

 

 

**4.9

 

Form of Unit Agreement (including Form of Unit Certificate)

**4.10

Form of Rights Certificate.Agreement (including Form of Rights Certificate)

 

 

 

*5.1

 

Opinion of Greenberg Traurig, LLP counsel to the Registrant.

 

 

 

*23.1

 

Consent of Greenberg Traurig, LLP (included in Exhibit 5.1).

 

 

 

*23.2

 

Consent of Independent Registered Public Accounting Firm.McGladrey LLP

 

 

 

***24.124.1

 

PowerPowers of Attorney (contained in(included on signature page).page to this Registration Statement)

**25.1

Form T-1 Statement of Eligibility under Trust Indenture Act of 1939 of Trustee

 


*                 Filed herewith.

**          To be subsequently filed, if applicable, by amendment or as an exhibit to a document to be incorporated or deemed to be incorporated by reference to this registration statement, including a Current Report on Form 8-K.

***Previously filed.Registration Statement.